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Summary
This programme of work examined the links between psychopathology and seizures 
for adults with epilepsy using longitudinal data from two datasets and employing 
state-of the-art analytic approaches to tease apart inter-relationships.
In the first study, using path analysis to examine direction of effects, a bi-directional 
relationship between seizure frequency and depression scores was confirmed. That is, 
not only did seizure frequency influence depression scores longitudinally and 
concurrently, but that depression scores also influenced seizure frequency 
equivalently.
The second study employed a latent variable structural equation modelling approach 
to examine moderation and mediation and prediction of change in variable scores over 
time. In this study although anxiety, perceived stress and depression all separately 
influenced changes in seizures (frequency and recency), depression mediated the 
relationship between both anxiety and stress with seizures.
The third study used a latent growth curve approach to focus on patterns of change 
within individuals. Trajectories of change in depression scores for individuals over 
time were examined as well as factors predicting this variation. This study found that 
seizure recency was a significant predictor of the individual differences in baseline 
depression scores as well as of the changes in depression scores over time for 
individuals with epilepsy.
The implications of these results are that both effective management of seizures and 
depression are essential for people with epilepsy. Given that the current focus of 
clinical management strategies for people with epilepsy is on seizure management,
this research suggests the importance of also identifying and managing depression 
amongst people with epilepsy. Strategies to implement this would include increased 
awareness of the importance of depression amongst clinical staff, improved screening 
for depression amongst people with epilepsy (for example by using depression 
screening questionnaires such as the Hospital Anxiety and Depression Scale), 
implementing effective treatment (such as by using antidepressants or cognitive 
behaviour therapy) if depression is identified.
Future aims would include confirming these findings using alternative designs, for 
example a randomised trial to investigate whether these links between depression and 
seizures arise because of a common antecedent factor or shared risk factors and 
examine whether other factors (such as gender) influence the relationships observed 
between depression and seizure outcomes.
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Overview of thesis
This thesis reflects the results of a programme of research on adult epilepsy. The 
central results of this programme of work have been published (2 papers) or have 
been submitted for publication (1 paper) in peer reviewed journals. These papers 
constitute three of the six chapters and for these chapters the material is in the 
published or submitted form. There will therefore be some repetition especially 
regarding methodology and on strengths and limitations of the work in the discussion. 
The other three chapters provide the background to the work, the methodology 
(samples, measures and analytic approach) and a general discussion which also 
incorporates the clinical implications of the findings and highlights ideas for future 
work. There is also a technical appendix which provides more details of some of the 
analytic strategies.
The primary objective of the programme of research presented in this thesis is to 
examine the interplay between depression and two seizure measures (frequency and 
recency) in a community based sample of adults with epilepsy. Using the attributes of 
a large scale, prospective, longitudinal research design, a set of interlocking studies is 
presented. These studies employ “state-of-the-art” data analytic approaches to 
examine the interplay between depression and seizure measures, and the role of other 
psychological factors, anxiety and perceived stress, that may explain variation in these 
seizure outcomes. The focus is on depression and anxiety symptoms rather than 
disorder in this thesis but the terms will be used interchangeably. Results are 
discussed throughout with a view to implications for clinical practice and for 
development of interventions.
This thesis is divided into six main sections.
Relevant background information on epilepsy and existing literature on depression, 
anxiety and stress amongst people with epilepsy is provided in the first section of this 
thesis. This section highlights that although depression, anxiety and stress seem to be 
quite common amongst people with epilepsy the exact nature of their inter­
relationship as well as their relationship with seizures is not clear. This section 
concludes with the main aims of the thesis.
The second section of this thesis focuses on Methodology. Information is provided 
about the individuals who participated in the studies included in this thesis and on the 
measures used. The rationale for using longitudinal methodology and the evolution of 
statistical techniques employed in this thesis are next discussed. The importance of 
using appropriate statistical methods to answer particular clinical questions is 
highlighted.
The third to fifth sections of this thesis relate to the three individual sets of analyses 
from the two studies that this thesis is based on. The first two represent published, 
peer reviewed papers and the third a paper submitted for publication. The first of these 
sections examines the directionality of links between depressive symptoms and 
seizure frequency using path analysis. The next section of this thesis explores how 
anxiety, stress and depressive symptoms are inter-related in their association with 
seizure frequency and recency. This section introduces the concepts of moderation 
and mediation and of using latent variable modelling. The fifth section of this thesis 
is based on inter-individual differences in depression scores and individual variation
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in changes to depressive symptoms over time amongst people with epilepsy. This 
section introduces an analytic method to examine this variation, latent growth curve 
modelling, and uses this method to examine whether seizure recency plays a role in 
explaining this individual variation in depression symptoms.
The results and implications of the above studies are discussed in the context of 
existing literature on this topic in the final section of the thesis. This section 
concludes with a summary of the main findings from this thesis.
Chapter 1:
Introduction
1
1.0. Introduction
Recent years have seen an explosion of interest in depression and on the links 
between depression and chronic diseases. Depression is responsible for the largest 
non-fatal disease burden in the world (Ustun et al, 2004) and has been found to have a 
larger impact on health than major chronic medical illnesses such as ischaemic heart 
disease, diabetes and osteoarthritis (Moussavi et. al., 2007). However depression often 
coexists with physical health problems (Moussavi et.al. 2007, Stein et.al., 2006, 
Farmer et.al, 2008), and in this situation, the impact on health is considerably greater 
than if only one problem was present (Moussavi et.al. 2007, Stein et.al., 2006, 
Merikangas et.al, 2007, Scott et.al, 2007).
Epilepsy is a common chronic neurological condition. The association of depression 
with epilepsy has been long appreciated (at least from the time of Hippocrates 
(Sykiotitis et.al. 2006)). Depression is at least as important a problem for people with 
epilepsy as it is for people with most other chronic diseases and may be commoner 
(Beghi et.al, 2002, Ettinger et.al, 2004, Anderson et.al, 2001). However longitudinal 
clinical research examining the links between depression and epilepsy has lagged 
behind research examining links between depression and some other chronic diseases 
(notably coronary heart diseases and diabetes). This situation has already led to 
considerable differences not only in awareness of the links between depression and 
chronic diseases but also in clinical management and government policies, with 
depression screening and management prioritised, and attracting payment for, 
individuals with diabetes and coronary heart disease but not for individuals with 
epilepsy in the new GP contract in the UK (DOH, 2006).
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However despite all this interest and recognition of the importance of the links 
between depression and chronic medical illnesses, the nature of the association 
between depression and chronic medical illness is still not well established 
(Musselman et.al, 2003, Whooley, 2006), both in terms of direction of effects and on 
how these links arise. These questions can only be answered if appropriate research 
designs are employed. Much of the current research is based on findings from cross- 
sectional studies which are inappropriate to establish direction of effects or answer 
questions on mechanisms (Rutter et.al, 2001). There has however been an increase in 
longitudinal research in recent years, which is more appropriate for answering 
questions on causal links than cross sectional research (Rutter et.al, 2001; Susser 
et.al., 2006). Longitudinal research has established that for people with some chronic 
illnesses such as diabetes, ischaemic heart disease and asthma, depression is a risk 
factor for the onset (Eaton et.al, 1996, Kawakami et.al, 1999, Whooley, 2006, Jonas 
et.al, 1999) of these disorders. There is also some research which has found that 
depression predicts the severity of illness in those with current illness (Roy et.al,
2007, Jiang et.al, 2005, Mancuso et. al., 2001).
Evidence has also emerged on the role of depression as a risk factor for the onset of 
epilepsy (Fosgren & Nystrom, 1990; Hersdorffer et.al, 2000; Hersdorffer et.al, 2006). 
However there has been little longitudinal research examining mechanisms and the 
direction of effects between depression and seizures for those with current epilepsy.
It is sometimes assumed that frequent seizures are a risk factor for depression in those 
with current epilepsy (Grabowska-Grzyb et.al, 2006) but the study designs employed 
in these studies are often inappropriate to study causation (Rutter et.al. 2001).
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It is essential to establish the nature of the associations so that intervention studies and 
clinical management can be planned accordingly (Kraemer et.al., 2002, MRC, 2000). 
To establish the mechanisms by which these links between depression and chronic 
illnesses may occur, it is important to examine existing research on how they arise 
(Rozanski et.al, 1999, Whooley, 2006). There are strong conceptual grounds and 
increasing empirical evidence in favour of considering depression as the end result of 
a causal or several causal chains of events (Kraemer et al 2001, DeKloet et.al., 2005). 
The situation seems similar for many other chronic diseases (Kraemer et.al., 2001). 
The pathway for the evolution of epilepsy is not clear but it has been argued that 
seizures too, are end results of progressive changes to the brain with cognitive and 
behavioural changes preceding the onset of seizures (Noebels, 2006).
Given that depression represents one end of a causal pathway, what other factors may 
be involved? We know that in the general population, anxiety, stress disorders and 
depression are closely linked. Anxiety has been found in some studies to precede the 
onset of depression (Merikangas et.al, 2003) and stress (Van Praag, 2004) and 
stressful life events have been recognised to be risk factors for depressive illness 
(Kendler et.al., 2002; Kendler et.al., 2006). Recent studies have also highlighted the 
importance of anxiety (Rozanski et.al 1999,Scott et.al, 2007), stressors and perceived 
stress (Cohen et.al., 2007) as risk factors for the onset and exacerbation of chronic 
medical illnesses. Moreover, it has also been found that when both anxiety and 
depression coexist with a physical illness the effect on health is much greater than if 
only one of these psychological disorders is present with the physical disorder 
(Rozanski et.al, 1999; Scott et.al., 2007). Stress, depression and anxiety have all been 
linked to dysfunction of the hypothalamo-pituitary axis (HPA axis) which has been
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suggested as having a role in the evolution of chronic physical illness (Rozanski et.al., 
1999;Gold & Chrousos, 2002, McEwen, 2007).
Anxiety and stress are common psychological problems amongst people with 
epilepsy. Anxiety has indeed been found to be the commonest psychological problem 
amongst people with epilepsy (Beyenburg et.al., 2005). Anxiety symptoms also seem 
more prevalent amongst people with epilepsy than in the general population (Jacoby 
et.al, 1996; Mensah et.al, 2007) and high seizure frequency has been associated with 
high levels of anxiety (Jacoby et.al, 1996, Ridsdale et.al., 1996,Mensah et.al, 2007). 
Stress has been highlighted as the main perceived risk factor for precipitating a 
seizure by people with epilepsy (Frucht et.al, 2000). There is however only limited 
information, as yet, on the relationship between frequent seizures and elevated levels 
of stress (Haut et.al., 2007). What is yet to be established is how these different 
psychological factors interact with each other in their association with seizures in the 
“web of causation” (Susser et.al., 2006). Possible roles could be as independent risk 
factors, antecedent factors, mediators, causal co-partners or even confounders (Susser 
et.al, 2006). It is important to establish the nature of the associations, to inform the 
development of services for people with epilepsy. To give an example, if there is 
evidence that anxiety mediates the relationship between depression symptoms and 
seizures and moderate anxiety was found to be present then the preferred first line 
treatment might be Cognitive Behavioural Therapy (NICE CG22, 2004) rather than 
antidepressants.
Finally we also know that the onset and course of depressive symptoms vary 
considerably within individuals amongst the general population (Judd et.al, 1998).
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Moreover, factors that affect depression symptoms in one individual may not affect 
others in the same way or to the same extent. There is however little information on 
how depression symptoms change over time for different individuals with epilepsy 
(intra-individual variation). Whilst we know that when we examine relationships 
between different individuals (inter-individual differences), seizure frequency is 
associated with variation in depression scores between individuals, we do not know 
what influence seizure activity has on how depression scores change over time within 
individuals (intra-individual variation). If seizure activity also explains this intra­
individual variation in depression scores, this would provide very strong empirical 
evidence for prioritising good seizure management as a means of improving 
depression. However if seizures were found not to predict intra-individual variation in 
depression scores, then this would lead us to re-examine our approach to 
management; for example, either seeking other factors which do explain this intra­
individual variability or simply ensuring effective depression management.
In next sections of this Chapter a brief background to the disorders and psychological 
factors (epilepsy, depression, anxiety and stress) considered in the thesis will be 
presented and the Chapter will conclude with the aims of this thesis.
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1.1: Epilepsy overview
1.1.1. Introduction
Epilepsy is a common chronic neurological condition. It is best understood as a 
family of related conditions (sometimes called the epilepsies) which are indicated by 
the individual suffering seizures (Engel & Pedley, 1998). Seizures are the 
manifestation of the underlying paroxysmal electrical disturbance in the brain. In most 
cases of epilepsy the precise aetiology is unknown, although with advances in brain 
imaging and genetic research, abnormalities in brain structure and genetic risk factors 
are being increasingly reported (Duncan et.al, 2006). Epilepsy can be also classified 
by whether the paroxysmal disturbance only affects part of the brain (“partial” 
seizures) or the whole of the brain (“generalised” seizures) both at onset and 
subsequently. There are also distinctions made by grouping clinical characteristics 
with specific types of seizures, and these are termed epilepsy syndromes.
1.1.2. Prevalence of Epilepsy
Epilepsy typically follows a relapsing and remitting course (Sillanpaa & Schmidt, 
2006). A considerable proportion of individuals who develop epilepsy may become 
seizure free subsequently (50% in the study quoted above (Sillanpaa & Schmidt,
2006)) and are able to discontinue their medication. This leads to the situation where 
although the lifetime prevalence of epilepsy is about 5%, the prevalence of active 
epilepsy (defined as having a diagnosis of epilepsy and either reporting a seizure in 
the last 5 years or being on medication for epilepsy) in adults is about 6 per 1000 
individuals (Jacoby et.al, 1996, Sillanpaa & Schnidt, 2006). The prevalence varies by
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age with reported prevalence rates of 4.5-5/10000 in children and adolescents, 6 per 
100 in adults aged 20-65 and 7 per 1000 in adults over 65 (Forsgren et.al., 2005).
The prevalence of epilepsy is approximately equal in males and females but some 
studies have found a slight male preponderance (Forsgen et.al., 2005).
1.1.3. Seizure characteristics
To quantify the severity o f epilepsy, several measures can be used. Seizure type, 
seizure frequency, seizure recency and seizure severity have been commonly used to 
describe the pattern of epilepsy in terms of impact (Baker et.al, 1998). For the 
purposes of simplicity, the term “seizure measures” will occasionally be used in this 
thesis rather than seizure recency or seizure frequency when making general 
statements about seizures, but should be interpreted as referring to either seizure 
recency or seizure frequency or both.
1.1.3.1. Seizure types
A variety of terminologies have been used in the past to describe epilepsy and these 
were often based on clinical features rather than on pathogenesis and these led to 
considerable difficulties in communicating findings, clinical management and 
diagnosis. Considerable efforts have been made in the last few decades in 
standardising terminology and basing it on the pathogenesis of the disorder. This led 
to the International League against Epilepsy (ILAE) Classification of epilepsy 
(Commission on Classification and Terminology of the International League Against 
Epilepsy ,1981 and Engel, 2001) which divides seizures into those with a partial or 
focal onset (initial localised activity in a part of the brain) and those with a 
generalised onset (initial widespread activity throughout the brain). This is an
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important distinction as there may be therapeutic implications and also in terms of 
considering the impact of epilepsy, as one of the most disabling aspects of seizures is 
unpredictability (Schneider & Conrad, 1983; Scambler, 1989). Those individuals who 
have a focal onset may get a warning (an aura) whereas those with a generalised onset 
will not. An outline of the ILAE classification system is presented in Figure 1.1.3.1 
(ILAE, 2008).
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Epileptic
Seizures
Generalised spread Epileptic spasms
Absence'
Absence'
Focal onset
Tonic clonicSimple partial*
Complex partial
Generalised
onset
Tonic clonic1 /tonic/ clonic
Others (include myoclonic, epileptic spasms and atonic).
Figure 1.1.3.1
Classification of epileptic seizures (adapted from International League Against 
Epilepsy classification 2006 (except * based on 1986 classification!- (ILAE, 2008).
'Formerly known as Grand mal seizures 
form erly known as Petit mal seizures 
includes Temporal Lobe epilepsy
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1.1.3.2. Using seizure types for research purposes
There are however considerable problems in using the above classification for 
research purposes in a pragmatic manner, certainly for community based samples.
1) A considerable proportion of people with epilepsy exhibit several types of 
seizures (Engel & Pedley, 1998).
2) Misdiagnosis o f both epilepsy (Scheepers et.al, 1998, Smith et.al., 1999) and 
seizure type is common (Benbadis, 1999, Forsgren et.al., 2005).
3) Precise seizure type often only becomes more apparent some time after initial 
consultation (Chowdhury et.al, 2008). By this time the patient may no longer 
be under specialist review and research suggests that many GPs either feel 
unconfident about their knowledge of epilepsy and about initial management 
or feel too time pressured to fully engage in epilepsy care. This may lead to 
problems with misclassification or non-classification of seizure type (Thapar 
et.al. 1998, Thapar, 2001). This is important as although the diagnosis of 
epilepsy is generally made in secondary care, most people with epilepsy are 
solely under the care of the primary care team (Thapar, 2001).
4) No definite diagnosis about precise seizure type is available in a significant 
proportion of medical records either because of errors of omission or of 
inconsistent labelling (with terms like major seizures and minor seizures used) 
in secondary care (Thapar, 2001).
5) For community based studies ascertaining seizure type can be difficult.
a. Recorded information on seizure type in primary care medical records 
can be used (Jacoby et.al., 1996 -  see Table 1.1) but often records are 
incomplete and there are errors of omission or of inconsistent labelling, 
as noted above (Thapar, 2001).
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b. Patient self reports are commonly used in prevalence studies. However, 
as a recent systematic review highlighted, self reports generally reflect 
the predominant manifestation of seizures and are likely to 
significantly under-report partial seizures which rapidly generalise and 
if EEG measurements are used, the proportion of individuals who will 
be found to have focal onset epilepsies will increase (Forsgren et.al., 
2005). However one secondary care EEG based study suggested, in 
contrast to the above, that patients were misdiagnosed as having partial 
epilepsy when in fact, using EEG recordings, they were suffering from 
generalised epilepsy (Benbadis, 1999).
To highlight some of these issues the results from a) a large community based study 
using recorded information (Jacoby, 1996) and b) the findings of a systematic review 
of European studies (Forsgren, 2005) are noted in Tablel. 1.3.2 As can be seen, there 
are considerable differences in prevalence rates reported, with community-based 
studies generally reporting the majority of seizures as generalised and hospital-based 
studies reporting partial seizures as being the most prevalent.
12
Table 1.1.3.2. Comparing information on seizure types from different types of 
study
a) Information on seizure type recorded in Primary Care records (Jacoby et.al, 1996)
Partial seizures only 12%
Generalised seizures only 40%
Combination partial/generalised seizures 17%
Information not recorded 31 %
b) Prevalence of seizure types from a systematic review (Forsgren et.al., 200 5 )
Partial seizures/localisation related epilepsies 55-83%
Primary generalised seizures 6-32%
Unclassifiable seizures 8-20%
In this thesis, for the above reasons, no distinction by seizure type will be made for 
most analyses.
1.1.3.3. Seizure frequency
Seizure frequency is simply a measure of how often seizures occur. The importance 
of seizure frequency as an outcome measure amongst people with epilepsy has been 
highlighted (Baker et.al., 1998). This is generally a self-report measure and is based 
on retrospective recall over a particular time period. Daily seizure diaries represent an 
advance but have only generally been used in fairly small samples. Most community 
based studies on adults with active epilepsy have found that about half of the sample 
have been seizure-free in the previous year, about a quarter have had more than a
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seizure a month and the remaining quarter have between a seizure a month and a 
seizure a year (Jacoby et.al, 1996, Thapar et.al., 2002). Most community based 
studies have not reported seizure frequency separately by seizure type.
1.1.3.4. Seizure recency
Another measure of seizure activity that has been used and reported on in several 
studies is that of seizure recency; that is, how long ago the individual had experienced 
the last seizure (Wagner et.a l., 1995, Cramer et.al., 2004). Some (Mrabet et.al,
2004) but not all studies (Leidy et.al., 1999) which have used both seizure frequency 
and seizure recency as outcome measures have found that both are associated with 
Quality of Life (QOL) measures. This issue was not discussed in the review paper on 
outcome measurement (Baker et.al, 1998).
1.1.3.5 .Seizure severity
Seizure severity has been used to try and encapsulate how the characteristics of a 
particular seizure (such as predictability/warning, recovery, tongue biting, 
incontinence) can be used to gauge the impact of a seizure (Baker et.al, 1991). This 
is ascertained generally by the score on a self report scale (the Liverpool seizure 
severity scale (Baker et.al, 1991) is the most widely used in the UK and has been 
shown to have good reliability and validity). Although it has been argued that much of 
the variation in the impact of epilepsy rests not on number of seizures but on the 
severity of seizures (Baker et.al, 1998), this measure has been little used in 
community based studies.
14
1.1.4. Aetiology and seizure precipitants
1.1.4.1. Aetiology
The aetiology of seizures is often unknown (idiopathic) although vascular injury 
(cerebrovascular disease), tumours, congenital causes, physical trauma (birth trauma, 
head injuries), or biochemical trauma (e.g. alcohol abuse) play a role for seizures in 
some individuals. A summary of the results from a recent systematic review of 
European population based incidence studies on presumed causes of epilepsy is given 
below in Table 1.1.4.1 (Forsgren et.al, 2005).
Table 1.1.4.1. Estimated proportion (%) of presumed causes of epilepsy in population
based incidence studies (Forsgren et.al., 2005)
Range
Unknown 44-69
Vascular 14-21
Trauma 2-16
Neoplasm 6-10
Genetic factors seem to play a role in a polygenic manner (Duncan et.al., 2006,
Greenberg & Pal, 2007) and seem especially important for the category termed 
idiopathic generalised seizures (Jallon & Latour, 2005) for which there is also a 
female preponderance (McHugh & Delanty, 2008) as opposed to a slight male 
preponderance for epilepsy overall.
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1.1.4.2 Seizure precipitants
Many factors have been suggested to be seizure precipitants (lack of sleep, stress, 
fatigue, alcohol, flashing lights, not taking medication, depression) but these are 
generally on the basis of patient perceptions rather than based on prospective studies 
(Nakken et.al., 2005)). Stress is the most commonly cited seizure precipitant, along 
with sleep deprivation (Nakken et.al., 2005, Haut et.al, 2007).
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1.2: Depression in Epilepsy
1.2.1: Depression in the general population 
1.2.1.1: Depression in the general population: Overview
Depression has been recognised as an illness from times of antiquity. Hippocrates 
used the term melancholia which he attributed to an excess of “black bile”, one of the 
four humours (Glas, 2003, Sykiotitis et.al. 2006). However it has been argued that 
this viewpoint restricted research and treatment approaches for depression for many 
years as it was felt to be a temperamental attribute rather than an illness (Glas, 2003). 
In recent years, the importance of depression has been increasingly highlighted 
(Murray & Lopez, 1997, Mathers & Loncar, 2006) and the impact on health either 
alone or in conjunction with other chronic medical disorders has become increasingly 
apparent (Stein et.al, 2006, Moussavi et.al., 2007, Farmer et. al, 2008). One of the 
studies, a global WHO funded study, showed not only that depression had a larger 
impact on health than major common chronic illnesses such as angina, asthma, 
diabetes and osteoarthritis but that the rates of depression amongst sufferers with 
these conditions were greater than for the general population and also if the two 
conditions (depression and chronic illness) coexisted, the impact on health was 
significantly greater than if the individual had either problem alone (Moussavi et.al.,
2007).
There are no objective biological tests for depression at the current time. The “gold 
standard” for diagnosing depression is using a standardised psychiatric interview but 
this is time and resource intensive so in many large scale research projects, depression 
is assessed using self rated questionnaires (such as the Hospital Anxiety and 
Depression scale, (HAD) (Zigmond & Snaith,, 1983), or the Center for Epidemiologic
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Studies Depression (CES-D) scale (Radloff, 1977). These questionnaires are 
standardised and have been extensively psychometrically tested and seem reliable 
measures (Eaton et.al., 2007).
1.2.1.2: Depression in the general population: categories
Depression is a heterogeneous condition. Depression can either be viewed 
categorically (“a clinical diagnosis” using either a psychiatric interview or using 
questionnaire scores above a pre-determined cut-off) or dimensionally (for example 
using questionnaire scores).
Diagnostic classification systems for psychiatry (DSM-IV (American Psychiatric 
Association, 1994), ICD-10 (WHO, 2007)) view depression categorically. Categories 
used in the DSM-IV classification include Major depressive disorder, dysthymia 
(chronic intermittent minor depression), cyclothymia (mild form of bipolar disorder) 
and bipolar disorder. Major depressive disorder can be further categorised as 
melancholic depression, psychotic depression and atypical depression depending on 
the precise mix of symptoms. ICD-10 (WHO, 2007) essentially categorises depressive 
disorders as bipolar or unipolar; as mild, moderate or severe; as single or recurrent, 
with or without psychotic features and has other categories of mood disorders such as 
cyclothymia. The diagnostic criteria for major depressive disorder using the DSM-IV 
classification system are highlighted in Figure 1.2.1.1. The importance of persistence 
of several symptoms as well as impairment in functioning is emphasised in this 
classification system. This system forms the basis of psychiatric interviews and 
generic instruments to score and identify depression.
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Figure 1.2.1.2.Major depressive disorder as defined by DSM-IV (American 
Psychiatric Association, 1994)
At least 5 of the following symptoms every day for at least 2 weeks with 
accompanied impairment of functioning and the symptoms must include either 
depressed mood and/or loss of interest.
♦depressed mood 
♦lack of interest 
♦weight loss 
♦insomnia
♦psychomotor agitation/ psychomotor retardation 
♦fatigue or loss of energy
♦feelings of worthlessness /excessive or inappropriate guilt 
♦diminished ability to think or concentrate 
♦recurrent thoughts of death.
1.2.1.3: Depression in the general population: using a dimensional approach.
The precise utility of considering major depression as a category however has been 
challenged (McCullough et al, 2003, Klein et al, 2006). It has, for example, been 
argued that chronicity and severity of symptoms are more crucial in terms of impact 
than the pattern of symptoms that meet diagnostic criteria (Klein et al, 2006). Also the 
implications of depressive symptoms are similar to those of major depressive disorder 
in terms of long term outcomes (Judd et.al., 1998, Klein et.al., 2006). Finally 
depressive symptoms are predictive of depressive disorder (Klein et.al, 2006) and are 
associated with increased service use (Johnson et.al, 1992). Overall, two different
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approaches have generally been adopted: 1) for epidemiological prevalence studies, 
diagnostic categorisation is generally used and 2) for clinical and aetiological 
research purposes a dimensional approach using depression symptoms has been 
recommended (Klein et.al, 2006).
1.2.1.4: Depression in the general population: Prevalence
There is considerable variation in estimates of the prevalence of major depressive 
disorder. A recent review, using pooled rates for large studies published between 
1980 and 2000 which met fairly rigid inclusion and exclusion criteria, estimated that 
the 1 year incidence rate was 2.9%, 1 year prevalence rate was 4.1% with a lifetime 
prevalence rate of 6.7% (Waraich et.al., 2004). However, higher figures on 
prevalence were found in the results from the large National Comorbidity Study 
Replication sample (Kessler et.al., 2003) which had not been included in the above 
review. Based on responses from 9090 adults, the lifetime prevalence of Major 
Depressive disorder was 16.2%, with a 12-month depression prevalence rate of 6.6%. 
In this study, for those in the latter group (that is, those who were depressed in the last 
12 months), the severity of depression, mean duration of depression and the presence 
of co-morbid anxiety were also determined. 10.4% of cases were classified as mild, 
38.6% as moderate, 38% were severe and 12.9% were classified as very severe. The 
mean episode duration was 16 weeks and 67% reported co-morbid anxiety. Other 
studies have found different prevalence rates and rates seem to depend on the sample, 
type of instrument used and definition of depression. It has been noted by some 
researchers that the prevalence of depression is likely to be increasing (Klerman & 
Weissman, 1989).
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1.2.2: Depression in people with epilepsy 
1.2.2.1: Depression in people with epilepsy: Overview
The association between depression and epilepsy has also long been recognised and 
goes back to the time o f Hippocrates (Robertson & Trimble, 1983). 1 le is reported as 
recognising the complex nature of the relationship and stating “melancholics 
ordinarily become epileptics, and epileptics melancholics: of these two states, what 
determines the preference is the direction the malady takes; if it bears upon the body, 
epilepsy, if upon the intelligence, melancholy” (quoted by Robertson & Trimble, 
1983). Most studies have reported that depression rates amongst people with epilepsy 
are higher than those commonly reported for the general population (Jacoby et.al., 
1996, Ridsdale et.al, 1996, Mensah et.al, 2006) or for those suffering from another 
chronic non-neurological condition (Ettinger et.al., 2004). The importance and 
difficulties o f identifying depression amongst people with epilepsy have been 
highlighted (Reynolds, 2005).
1.2.2.2: Depression in people with epilepsy: clinical manifestations
It has been argued that the pattern of depressive disorder amongst people with 
epilepsy has been reported as being different to the pattern of depression in the 
general population. For example, symptoms such as irritability appear to occur more 
commonly amongst people with epilepsy and symptoms are often more intermittent 
and occur in more atypical clusters (Blumer et.al, 2004). Also groups have been 
described for which there is no equivalence in the general population (such as Ictal / 
Peri-ictal depressive symptoms (mood disturbance closely related to individual 
seizures) and mood symptoms related to anti-convulsant use).
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1.2.2.3: Depression in people with epilepsy: Using a dimensional approach.
As for the general population depression can be viewed dimensionally as well as 
categorically in those with epilepsy. Research on this is however much more limited. 
From the preceding discussion on the different manifestations of depression amongst 
people with epilepsy, treating depression dimensionally may be advantageous. Many 
of the individuals with more atypical manifestations of depressive disorder and ictal 
and peri-ictal depressive disorders would not be captured using a categorical, DSM- 
IV diagnostic criteria based approach. The arguments for treating depression 
dimensionally in the general population would also hold for those with epilepsy.
1.2.2.4: Depression in people with epilepsy: Prevalence
It has been argued that the prevalence of major depression as defined by the DSM-IV 
classification system (American Psychiatric Association, 1994) is higher amongst 
people with epilepsy than in the general population (summarised in Kanner, 2003). 
However there are considerable differences in reported prevalence figures of major 
depressive illness. Community based studies have reported overall rates of 10-15 % 
((Jacoby et al, 1996 (11%), O’Donaghue et. al, 1999 (10.3%), Gaitatzis et.al. 2004 
(13.6%), Thapar et.al., 2005(11%)) whereas clinic /hospital based studies have 
generally reported rates of 20-50% (e.g. Grabowska-Grzypa et al., 2006. (49.2%)).
There is less research on the prevalence rates for other subtypes of depression 
amongst people with epilepsy. Some studies have found prevalence rates of up to 
50% for the more atypical patterns of depressive symptoms (Blumer, 1997, 2004, 
Mendez et.al., 1986) and for dysphoric mood disturbance over the three days before a
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seizure (Blanchett & Frommer, 1986). There is very little research on the prevalence 
of individual depression symptoms for people with epilepsy.
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1.3: Anxiety amongst people with Epilepsy
1.3.1: Anxiety in the general population 
1.3.1.1: Anxiety in the general population: Overview
The distinction between clinically defined anxiety disorders and everyday feelings 
such as fear and restlessness has been recognised for at least 2500 years but the 
generally accepted distinction between anxiety and depression only dates to the mid- 
19th Century (Glas, 2003). Anxiety disorders are the most common psychiatric 
disorders (Kessler et.al., 2005). Like most common chronic disorders, anxiety 
symptoms seem to be continuously distributed amongst the population, with most of 
the general population having few anxiety symptoms unless associated with specific 
life events or stresses and the rest of the population having a range of symptoms 
(Kessler et.al, 2005, Kendler et.al., 1998). There has been much less published 
research on the consequences of anxiety disorders than on the consequences of 
depressive disorders until very recently. Recent reports have found that anxiety 
disorders and symptoms can have important consequences on functioning and health 
of individuals (Kroenke et.al., 2007, Roy-Byme et.al, 2008, Frasure-Smith et.al.,2008)
1.3.1.2: Anxiety and stress in the general population: Subtypes
Anxiety can be described by clustering symptoms into categories (such as by using 
the DSM-IV classification, discussed later), by severity (such as mild, moderate or 
severe), by aetiology (such as Post Traumatic Stress disorder) as well as by impact on 
functioning.
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1.3.1.2.1. DSM-IV defined anxiety
DSM-IV defines 12 types of anxiety disorders. These include generalised anxiety 
disorder, phobias, panic disorder, post-traumatic stress disorder amongst others (APA, 
1994). As an example of the type of symptoms encountered in anxiety disorders, the 
diagnostic criteria for Generalised Anxiety Disorder using DSM-IV are highlighted 
below (Table 1.3.1.2.1). In line with the DSM-IV criteria for depression it is 
necessary for several symptoms to be present and persistent and functioning to be 
impaired but for DSM-IV generalised anxiety disorder symptoms can be somewhat 
intermittent but over longer period and the difficulties in controlling the symptoms are 
emphasised.
Table 1.3.1.2.1 : The diagnostic criteria for Generalised Anxiety Disorder 
according to DSM-IV.
These are as follows:
1. For more than half the days in at least 6 months, the patient experiences excessive 
anxiety and worry about several events or activities.
2. The person has trouble controlling these feelings.
3. Associated with this anxiety and worry, the patient has 3 or more of the following 
symptoms, some of which are present for over half the days in the past 6 months:
*Feels restless, edgy, keyed up.
*Tires easily.
*Trouble concentrating.
* Irritability.
* Increased muscle tension.
*Trouble sleeping (initial insomnia or restless, unrefreshing sleep).
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4.The symptoms cause clinically important distress or impair work, social or personal 
functioning.
5.The disorder is not directly caused by a general medical condition or by substance 
use, including medications and drugs of abuse.
6.It does not occur only during a Mood Disorder, Psychotic Disorder, Posttraumatic 
Stress Disorder or Pervasive Developmental Disorder.
1.3.1.3: Anxiety in the general population: A dimensional approach
It has been argued that anxiety disorders should be treated dimensionally to maximise 
reliability and validity and retain the categorical approach for clinical utility (Andrews 
et.al., 2008). A dimensional approach for both clinical and research purposes is also 
suggested by other types of empirical evidence. Genetic studies have found similar 
patterns of heritability for most of the subtypes of anxiety, and it seems to be the 
predisposition to any anxiety disorder that is inherited rather than the specific subtype 
(Smoller et.al, 2008). Research on co-morbidity for the different types of anxiety 
disorders found that all these disorders could be detected adequately using the same 
brief screening instruments (Kroenke et.al, 2007). Interestingly, distinctions between 
different types of anxiety disorders have only been highlighted in the more recent 
versions of the DSM classification (particularly in DSM-IV). In the past, DSM-II 
only really distinguished between anxiety neurosis and specific phobias (Cassano 
et.al, 2003).
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1.3.1.4: Anxiety in the general population: Prevalence
Anxiety disorders are the commonest form of psychiatric disorder (Kessler et.al, 
2005). Although there is some variation in reported prevalence rates of anxiety 
disorders, the findings from the recent National Comorbidity survey indicated a 
lifetime prevalence of any anxiety disorder of 28.8%, 12-month prevalence rate of 
18.1% for any anxiety disorder and of 5.7% for generalised anxiety disorder (Kessler 
et.al., 2005).
1.3.2: Anxiety amongst people with epilepsy
1.3.2.1: Anxiety amongst people with epilepsy: Overview.
The association between epilepsy and anxiety has been long recognised (the term 
melancholia used in Hippocratic times having an overlap with both anxiety and 
depression (Glas, 2003)). Anxiety disorders have been found to be more common 
amongst people with epilepsy than for the general population (Beyenberg et.al, 2005).
1.3.2.2: Anxiety amongst people with epilepsy : Clinical manifestations
Anxiety symptoms, like depression symptoms, can be related to epilepsy in a variety 
of ways (Goldstein & Harden, 2000). They can be independent of individual seizures 
(interictal), related closely to individual seizures (ictal or peri-ictal), as part of the 
more atypical depressive symptom complex described earlier or related to medication 
side effects(Valquez & Devinsky, 2003). The DSM-IV classification can be used to 
categorise inter-ictal anxiety disorders (Vazquez & Devinsky, 2003).
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1.3.2.3: Anxiety amongst people with epilepsy: A dimensional approach
There has been little discussion of this topic in the epilepsy literature. The DSM-IV 
classification system has a category for anxiety explained by medical conditions 
(APA, 1993). Most reported research on anxiety amongst people with epilepsy does 
not use DSM-IV anxiety disorder categories and instead relies on results from self- 
report anxiety rating scales (Beyenburg et.al, 2005) with cut off scores on these 
questionnaires to define whether or not clinical anxiety is likely to be present (Jacoby 
et.al., 1996). The cut-off scores have generally been recommended on the basis of 
research in the general population, although the risks of applying these scores to 
people with epilepsy have been highlighted (Krishnamoorthy, 2006). There is some 
recent tentative neurobiological evidence to support analysing anxiety scores as a 
dimension. A recent study on patients with intractable temporal lobe epilepsy found 
post-operative anxiety scores were associated with the volume of the left hippocampal 
remnant after anterior temporal lobectomy. However a weakness of the study was 
that no pre-operative psychological assessments were carried out (Paparrigopoulos 
et.al., 2008).
1.3.2.4: Anxiety amongst people with epilepsy: Prevalence
The prevalence of anxiety amongst people with epilepsy in community based studies 
has been found to be consistently higher than in the general population. The reported 
prevalence rates however vary considerably (as for depression), with point prevalence 
rates of over 20% ( 20.5% (Mensah et.al., 2007), 25% (Jacoby et.al, 1996), 30.4% 
(Ridsdale et.al, 1996) and 39.4% (O’Donaghue et.al., 1999). Hospital based studies 
have found even higher rates o f anxiety, with some studies reporting rates of over 
50% (Beyenburg et.al., 2005).
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1.4: Stress amongst people with Epilepsy
1.4.1. Stress in the general population:
1.4.1.1: Stress in the general population: Overview
Stress is a difficult concept to define (Cohen et.al., 1997) . One approach has been to 
emphasise the importance of homeostasis for living organisms. Using this approach 
stress would be any physical or psychological event (a stressor) which threatens this 
state of dynamic equilibrium (De Kloet et.al, 2005). However individuals vary 
greatly in their response to stressors (Cohen et.al., 2007). Another approach to stress 
emphasises the importance of stress appraisal, where it is the individual’s subjective 
perception of stress which is important. A useful working definition which may unify 
some of these concepts is “(stress) is a process in which environmental demands tax 
or exceed the adaptive capacity of an organism, resulting in psychological and 
biological changes that may place persons at risk for disease” (Cohen et.al., 1997).
Disease causation and exacerbation are often linked to the presence of stress by the 
general population (Cohen et.al., 2007). There is mixed evidence on the impact of 
both stressors and stress appraisal on health. A recent commentary in the Journal o f 
the American Medical Association (JAMA) highlighted the studies which had found 
increased risks of physical illness in those reporting stress or stressful life events 
(Cohen et.al, 2007). There is also some research which suggests that stress appraisal 
is not a risk factor for diseases such as coronary heart disease (Mcleod et.al, 2002) but 
the measure used to measure stress appraisal has been criticised (Hotopf, 2002, 
Rosch, 2002).
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1.4.1.2: Stress in the general population: categories
The DSM -  IV classification system has no equivalent framework to the schemata of 
stressors and stress appraisal outlined above and is instead based on acute symptoms 
after a stressor or long term problems with adjustment. The DSM-IV system lists 
categories for Acute Stress reactions, Adjustment Reactions (both of these are limited 
to 6 months after an event (stressor)) and Post Traumatic Stress disorder.
The advantages of using stress appraisal (sometimes termed perceived stress or 
subjective stress) have been highlighted (Cohen et al, 1997).
1.4.1.3: Stress in the general population: a dimensional approach
As discussed above, measurement of stress can be undertaken either by using 
questionnaires, interviews or by biological measurements (such as cortisol) (Cohen 
et.al, 1997). Interviews are generally recommended but questionnaires are also used 
and are acceptable (Cohen et.al, 1997). Questionnaires can be either used to measure 
exposure to stressors (using instruments such as the Holmes-Rahe social readjustment 
scale) or by measuring stress appraisal (such as by using the Perceived stress scale) 
(Cohen et.al, 1997). Both of these constructs are usually used dimensionally. Some 
studies have reported on prevalence figures using categories, based on cut-off scores.
1.4.1.4: Stress in the general population: prevalence
Here, the emphasis is on perceived stress not on life events, the measurement of 
which has been extensively discussed (Cohen et.al, 1997). The prevalence of reported 
stress in the general population depends on the type of measure used and the sample. 
In a study based on adults in Sweden which used the Perceived Stress Questionnaire, 
the prevalence of moderate stress was estimated to be 10.0% and the prevalence of
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high stress 4%. Higher stress levels were reported by women, with the highest 
prevalence in the 30-34 age group (Bergdahl & Bergdahl, 2002). In a further 
European study using the same questionnaire, the prevalence rate of moderate stress 
was 14.5% and prevalence of high stress was 3.1% with highest scores in the 35-54 
age group (Kocalevent et.al., 2007).
1.4.2: Stress amongst people with epilepsy 
1.4.2.1: Stress amongst people with epilepsy: overview
The psychological strains of living with epilepsy were well documented in early 
qualitative research by Graham Scambler (Scambler, 1989) and Peter Conrad and 
Joseph Schneider (Schneider & Conrad, 1983). Qualitative work has continued to 
document the adverse life circumstances of people with epilepsy. However there has 
been little use of quantitative measures of stressors and stress appraisal amongst 
people with epilepsy. Most of the reported research has focussed on the role of stress 
as a seizure precipitant. Studies have supported the role of both environmental stress 
(i.e. life events) (Rajna & Veres, 1989) and perceived stress (Temkin & Davis, 1984, 
Mattson, 1991, Frucht et.al, 2000, Spector et.al, 2000, Haut et al, 2007, Nakken et al, 
2005,Sperling et.al, 2008) as a seizure precipitant. However most of these studies are 
small and have not controlled for emotional state either as a confounder or as a 
moderator. The aetiology of stress in epilepsy is not precisely understood. Epilepsy 
leads to a variety of handicaps. Seizures can be highly embarrassing especially if 
coming on without warning. Seizure frequency and type are also extremely important 
in this regard. Idiopathic epilepsy is also common in adolescence and this is a 
vulnerable period in terms of self image. The social consequences of epilepsy 
including stigma and employment problems have been highlighted for many years
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(Scambler, 1989) and social difficulties such as problems with employment and 
economic circumstances are still evident (Smeets et.al, 2007).
1.4.2.2: Stress amongst people with epilepsy: subtypes
There seems to have been little research looking at the relationship of specific 
subtypes of stress and epilepsy. There have been several studies which have found 
increased rates of PTSD amongst individuals with pseudo seizures. One study has 
found increased rates of post-traumatic stress disorder (PTSD) amongst people with 
intractable epilepsy as well as those with pseudo seizures (Rosenberg et.al., 2000).
1.4.2.3 : Stress amongst people with epilepsy: a dimensional approach
As discussed above there has been little quantitative research examining stress 
amongst people with epilepsy. Qualitative research has highlighted the individual 
experiences of individuals with epilepsy which would lead to the suitability of using a 
dimensional approach (Schneider & Conrad, 1983, Scambler, 1989).
I.4.2.4.: Stress amongst people with epilepsy: prevalence
Data on the prevalence of high levels of stress amongst people with epilepsy are not 
available. Qualitative work (Schneider& Conrad, 1983, Scambler, 1989) suggested 
that stress is a common problem amongst people with epilepsy. Quantitative work 
does not generally report prevalence levels of background stress but instead has 
examined the role of stress as a precipitant for seizures (Haut et. al. 2007).
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1.5 : Aims
The overall aims of this programme of research are to systematically examine the 
relationship between depression and seizure measures in adults with epilepsy using 
data from large scale, prospective longitudinal studies and “state-of-the-art” data 
analytic strategies to also examine the influence of other psychological variables on 
two principal seizure measures.
Specific aims include:
1) To examine the nature of the relationship between depression symptom scores and 
seizure frequency amongst people with epilepsy by specifying and testing different 
theoretical explanatory models of this relationship.
2) To examine how depression, anxiety and stress act separately and in combination 
to influence seizures.
3) To examine the pattern and extent of individual variation in depression symptom 
scores amongst people with epilepsy over time.
4) To investigate whether seizure recency predicts individual variation in depressive 
symptoms.
5) To tailor and apply appropriate multivariate statistical analytic techniques to 
examine the specific relationships postulated.
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Chapter 2:
Methods overview
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2.1. Introduction to the datasets used: subjects and measures
Information from two community-based studies of adults with active epilepsy was 
used for the analyses.
2.1.1.Study 1.
2.1.1.1. Sample
The sample consisted of adults with active epilepsy who were recruited from 82 
general practices in Greater Manchester and who consented to participate in an 
intervention study to assess the effectiveness of an epilepsy prompt and reminder card 
in improving quality of care (Thapar et.al, 2002). This study had taken place from 
1996 to 1999. Ethical approval was obtained from the relevant local Research Ethics 
Committees (South Manchester, Bury and Rochdale, Salford and Trafford and 
Stockport).The definition of active epilepsy used was that of either a seizure recorded 
in the medical records in the last two years or currently on anticonvulsant medication 
for epilepsy with a history of epilepsy. The sample is described in further detail in 
Section 2.2.
2.1.1.2. Measures
All patients had been sent a battery of questionnaires for self- completion. Data were 
collected at two time points 1 year apart. For the purposes of the analyses contained 
in this thesis the following measures were used
1) Seizure frequency. This was a measure from the battery of questionnaires 
combined to form the Liverpool Quality of Life questionnaire (Baker et.al., 
1993). Seizure frequency was assessed using a self-report measure rated on the
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response to a question “How many epileptic attacks have you had in the past 
year” with the three response categories being “None”, “Less than one a 
month” and “One or more a month”. This item has been shown to have good 
reliability and validity (Baker et.al., 1993).
2) Depression scores. These were derived from the Hospital Anxiety and 
Depression Scale (HAD) (Zigmond & Snaith 1983). These are based on 
responses to seven questions pertaining to depressive symptoms and the range 
of possible scores on the HAD depression subscale range from 0 to 21. This 
measure has been shown to have good reliability and validity (Zigmond & 
Snaith 1983).
2.1.2. Study 2
2.1.2.1. Sample
A cohort of adults with active epilepsy was recruited to participate in a longitudinal 
three-wave 15 month observational study of factors affecting the quality of life of 
people with epilepsy. Active epilepsy was defined as individuals with a history of 
epilepsy who were either on medication for their epilepsy or who had had recent 
seizures. Individuals identified through general practices who had taken part in 
previous studies in Cardiff (Mensah et.al., 2006) and Manchester (Thapar et.al., 2002) 
were contacted and invited to participate in the present study and 341 individuals from 
Cardiff and 108 individuals from Manchester agreed to participate. Ethical approval 
was obtained from the relevant local Research Ethics Committees (BroTaf and 
Salford & Trafford). A volunteer sample of people with epilepsy was also recruited 
through Epilepsy Action (115 individuals). Information was collected at three time
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points about 5 months apart. The study took place between 2002 and 2004. This 
sample is described in further detail in Section 2.2.
2.1.2.2. Measures
Participants completed a comprehensive package of well-known and validated 
measures of physical, social and psychological health1.
The following subset of measures was used for the analyses contained within the 
thesis.
1. Anxiety and Depression. The Hospital Anxiety and Depression (HAD) scale was 
used (Zigmond & Snaith, 1983). This is a widely used measure with good 
psychometric properties which has been successfully used to measure caseness for 
depression and anxiety in previous community based studies examining the quality of 
life of people with epilepsy (Jacoby et.al., 1996). It refers to how the respondent had 
been feeling in the previous week. Depression and anxiety scores were also 
categorised into “normal”(score from 0-7), “borderline “ (scores 8-10) and “probable 
case” (scores 11 or above) (Zigmond & Snaith, 1983, Snaith, 2003).
2. Perceived stress. The 4 item perceived stress scale PSS (Cohen et.al., 1983) was 
used as a measure of stress appraisal. It referred to perceived stress levels in the past 
month. The 4 item scale was used to minimise respondent burden. It has been found 
to have acceptable psychometric properties (Cohen et.al., 1983) and has been used in 
previous outpatient and community studies (Farabaugh et.al., 2004).
3. Seizure recency. (Wagner et.al., 1995; Cramer et.al, 2004). Participants were 
asked how long it had had been since they had their last seizure. This measure has
1 a full list of measures is available upon request
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been used in previous studies (Cramer et.al, 2004). The responses were converted to 
days since last seizure and categorised. A 12 category variable was created with 
scores ranging from 12 (seizure in the last 24 hours) to 1 (last seizure was more than 
15 years ago) with a midpoint score of 6 (last seizure was between 6 and 12 months 
ago), that is, with the most recent seizures having the highest scores. Categorization 
was used for conceptual and clinical reasons as well as to overcome problems with 
model convergence.
4. Seizure frequency. Individuals were also asked about the number of seizures they 
had experienced over the previous year with scores ranging from 0 (if the individual 
had had no seizures) to 10 (if the individual had 10 or more seizures) in the previous 
year.
5. Medication compliance. Individuals were also asked to rate how often they missed 
any medication for their epilepsy at the end of the study. Responses were on a 4 point 
Likert Scale and ranged from 1= “never” to 4= “missed doses more than once a 
week”.
2.1.2.3. Missing values
Some individuals had missed items on particular scales. A two step approach was 
used in dealing with missing values. Where there was partial non completion of 
scales (for seizure recency and seizure frequency), regression based imputation 
methods for missing data were used (standard missing values procedure used in 
STATA Version 8) or (for depression and anxiety) if there was a single item with a 
missing value then imputation using mean substitution derived from the other items 
was undertaken. If there was more than one missing item the score was coded as 
missing.
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List wise deletion of data was undertaken prior to the structural equation modelling 
analyses such that only individuals with complete information for all variables were 
included in all subsequent analysis.
Data transformations
The data were also transformed; anxiety and depression scores were negatively 
skewed so were transformed using a square root (raw score+1) transformation. 
Analyses were carried out on transformed data.
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Chapter 2.2: Study sample
2.2.1. Study 1
At baseline the sample consisted of 1210 adults with epilepsy. Some participants did 
not provide complete data so numbers for different items may be less than this 
number. The characteristics of the sample have already been published (Thapar, 
2001). Percentages are rounded to one decimal place so some cumulative percentages 
will not equal 100%.
Table 2.2.1. Sample characteristics :Study 1
Age («=1210)
Mean age (S.D.) (years) 49.6(17.3)
Age group (years) »(%)
20 or younger 41 (3.4)
21-40 364 (30.1)
41-60 453 (37.4)
61-80 321 (26.5)
81 or older 31 (2.6)
Sex (w=1209), n (%)
Male 580 (48.0)
Female 629 (52.0)
Seizure type («=596), n (%) (may have more than one seizure type— % will add up to 
more than 100%)
Generalized—tonic—clonic 332 (55.7)
Partial—simple 28 ( 4.7)
Partial—complex 182 (30.5)
Others, including absence seizures 220 (36.9)
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Table 2.2.1.(cont) : Sample characteristics :Study 1
Family history -  first degree relatives with epilepsy («=955), n (%)
Yes 97(10.2)
No 858 (89.8)
Seizure frequency Time 1 («=1197), n (%) Time 2 («=954), n (%)
No seizures in the last year 607 (50.7) 527 (55.2)
<1 Seizure/month 261 (21.8) 194 (20.3)
>1 Seizure/month 329 (27.5) 233 (24.4)
Depression scores Time 1 (w=l 185), mean (S.D.)
Time 2 (w=959), mean 
(S.D.)
Total score 5.34 (3.8) 5.37 (4.0)
Categorized depression 
scores Time 1, n (%) Time 2, n (%)
“No depression” (0-7) 878 (74.1) 694 (72.4)
“Doubtful depression” (8- 
10)
170(14.3) 141 (14.7)
“Definite depression” (11- I 137 (11.6) 
21)
124(12.9)
Marital status (n= 1204) %
r
Single 25.8
J Married /living as married 56.7
Divorced /separated 9.3
Widowed 8.1
Age of onset of epilepsy (n=l 169) n (%)
Aged 18 or earlier 507(38.8)
Aged 19-60 551 (42.2)
Aged over 60 111 (8.5)
Claim income support (n=l 134) n (%)
Yes 251 (22.1)
No 883 (77.9)
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2.2.2. Study 2
The numbers of participants in this study were 460.
Some participants did not provide complete data so numbers for different items may 
be less than this number. Most single data point information is based on baseline 
characteristics except data on seizure type and family history that are based on data 
collected at the end of the study. Percentages are rounded to one decimal place so 
some cumulative percentages will not equal 100%.
Table 2.2.2. Sample characteristics : Study2
Age (w=447)
Mean age years (S.D.) 51.1 (17.3)
Age group (years) n (%)
20 or younger 3 (0.7)
21-40 112(26.6)
41-60 180 (42.8)
61-80 103 (24.5)
81 or older 23 (5.5)
Sex («=460), n (%)
Male 217(47.2)
Female 243 (52.8)
Seizure type («=344), n (%)
(may have more than one seizure type— % will add up to more than 100%)
Generalized—tonic—clonic 174 (50.6)
Partial—simple 65(18.9)
Partial—complex 89 (25.9)
Others, including absence seizures 169 (29.1)
Fist degree family history (»=382), n (%)
Yes 34 ( 8.9)
No 348 (91.1)
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Table 2.2.2. (continued). Sample characteristics : Study 2 (continued)
Seizure frequency
Time 1
(w=452), n (%)
Time 2
(w=434), n (%)
Time 3
(n=390), n(%)
No seizures in the last year 224 (49.6) 221 (50.9) 211 (54.1)
<1 Seizure/month 113(25.0) 97 (22.4) 86(22.1)
>1 Seizure/month 115(25.4) 116(26.7) 93 (23.8)
Depression scores
Time 1 
(«=460), 
mean (S.D.)
Time 2 
(w=435), 
mean (S.D.)
Time 3 
(«=395), 
mean (S.D.)
Total score 4.10(3.33) 4.42 (3.59) 4.40 (3.54)
Marital status (n= 460) n (%)
Single 123 (26.7)
Married /living as married 262 (57.0)
Divorced /separated 39 (8.5)
Widowed 36 (7.8)
Employment status (n=447) n(%)
Employed 181 (40.5)
Unemployed, seeking work 15(3.4)
Retired from paid work 126 (28.2)
Permanently unable to work 
(illness / disability)
78(17.4)
Other 47(10.5)
Claim income support (n=433) %
Yes 14.8
No 85.2
As Sample 2 was recruited from three different localities (see Page 36) the 
characteristics of the sample recruited from each of the three localities is compared 
below (Table 2.2.2.1 on next page)
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Table 2.2.2.I. Characteristics of individuals recruited from the three different 
localities (see Page 36)...
Sample characteristic Cardiff sub­
sample
Manchester
sub-sample
Epilepsy Action 
sub-sample
% Male (n) 49.6(133) 50.0 (46) 38.0(38)
Mean age in years (n) 52.7 (263) 53.9(87) 44.4(97)
Mean categorised days since last 
seizure* (n)
5.7(270) 6.0 (96) 7.8(101)
% Seizure free in previous year 
(n)
^57.4(147) 53.7 (51) 25.7(26)
% of individuals reporting 
complex partial seizures as one 
of seizure types (n)
16.6 (31) 22.9(16) 48.3 (42)
Mean depression score (n) 4.0 (267) 4.0 (93) 4.5(100)
♦defined on Pages37-8
2.2.3. Were the samples representative?
To check whether the samples being used were representative, a comparison was 
made of the characteristics of the respondents in these samples to the findings of 
another large, unrelated, community based study of adults with epilepsy (Jacoby, et al, 
1996). The main comparisons are listed in Table 2.2.3 (below).
Table 2.2.3 Comparing sample characteristics in the present study to those from 
another well characterised community based study
Sample characteristic Sample 1 Sample 2 Jacoby et al, 1996 
study
Seizure free in previous 
year (%)
50.7 52 53
Tonic-clonic seizures 
(%)
55.7 50.6 52*
Employed (%) N/A 41.3 44.8
Male(%) 48 47 49
Mean age (years) 49.6 51 46
* questionnaire responders
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2.3. Overview of Statistical analyses
2.3.1. Background
Previous work has examined the links between psychopathology and seizures for 
people with epilepsy (see Chapter 1 for more details).
This existing evidence is of four principal types, namely:
1) Evidence from qualitative studies (Scambler, 1989, Schneider & Conrad, 
1983). These have highlighted that people with epilepsy report a lot of 
difficulties with stress and mood in their day to day lives.
2) Evidence from cross-sectional surveys. These show increased prevalence 
rates of psychopathology amongst people with epilepsy, for example, anxiety 
disorders are commoner in epilepsy (Tellez-Zentano et.al., 2007).
3) Evidence from cross-sectional studies examining associations (Jacoby et. al, 
1996, Ridsdale, 1996). These have found that there are associations between 
seizure factors and psychopathology. One example is that the frequency of 
seizures is associated (correlated) with higher rates of depression amongst 
people with epilepsy (Jacoby et. al., 1996).
4) Evidence from studies which have looked at “causal” relationships using 
regression. These have found that seizure factors predict psychopathology.
One example is that complex partial seizures are found to predict depression 
scores (Grabowska-Grzyp et al., 2006).
However these previous studies leave many important questions unanswered and have 
several methodological limitations.
1) All the analyses to date are based on cross-sectional data. It is generally 
acknowledged that for observational studies which examine causes and
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consequences, longitudinal data should be used (Menard, 1991, Rutter et.al., 
2001, Academy of Medical Sciences, 2007). This is discussed in more detail 
below.
2) Several psychopathological factors have been associated with seizures (such as 
anxiety and depression) and these are closely inter-related and inter­
relationships are likely to be complex (Susser et al, 2006). To examine 
complex relationships, appropriate methods have to be employed (Tabachnick 
& Fidell, 2001). There are several reasons why simpler techniques like 
multiple regression may not be appropriate:
a) There is a need to take account of the precise relationship between 
psychological variables (e.g. mediation and dealing with correlated 
variables),
b) the errors associated with measuring these correlated variables may 
themselves be correlated and
c) there can only be one dependent variable. Statistical analytic methods 
which are able to deal with higher levels of complexity have to be 
adopted.
The data on which this thesis are based are longitudinal. Path analysis and structural 
equation modelling (SEM) were used for the analyses.
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2.3.2. Key concepts
2.3.2.1. Longitudinal data
What are the advantages o f using longitudinal data?
There are different types of longitudinal data. Where information from the same 
informants is collected over at least two occasions separated temporally this is termed 
as panel data. For studying causal relationships, longitudinal (panel) data rather than 
cross sectional data should be employed for the following reasons:
1) Temporal or causal ordering is an essential part of testing directionality of 
effects and hence for examining causal hypotheses. For this you generally 
need longitudinal data.
2) Longitudinal data allows measurement of intra-individual changes, whereas 
cross-sectional data only allows measurement of inter-individual differences. 
This is especially important if any changes over time (“developmental 
changes”) are expected.
3) For any dynamic process, longitudinal data are necessary to estimate 
parameters (characteristics of population or distribution of scores) efficiently 
and without bias (Menard, 1991). Panel data can be used to identify and 
correct for residual heterogeneity.
4) Prospective panel designs are the best method for longitudinal analysis of 
observational data (as opposed to retrospective methods).
2.3.2.2.Examining relationships amongst causes -  moderation and mediation
As highlighted above, longitudinal data are useful for studying causal relationships. 
However often the hypothesised cause is simply one of a range of possible risk factors 
impacting on the disorder and works in conjunction with other risk factors (Susser
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et.al. 2006). By anticipating the roles that other factors may play in the hypothesised 
relationship enables data to be collected on these other factors and consequently to 
inform the analyses for causal explanation; that is, not only looking at the range of 
causes of disease but elucidating how different causes inter-relate (Susser et.al.,
2006). Types of causes can be subdivided into those that are not in the hypothesised 
causal pathway (either as independent risk factors or confounders (associated with the 
postulated cause as well as the outcome but not on the causal pathway)) and that other 
factors are inter-related in the causal pathway either as mediators, antecedent causes 
or as causal partners (for which moderation is one example). This is summarised in 
Figure 2.3.2.2 (overleaf)
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Figure 2.3.2.2: Diagrammatic representation of how an additional risk factor
could impact on a postulated relationship between a risk factor X and an
outcome Y (adapted from Susser et.al, 2006)
A n teced en t cau se
M ediating risk factor
Independent risk factor
Confounder
M oderator
2.3.3. Evolution of the analytic approach
The analytic approach used utilises the family of techniques termed structural 
equation modelling (SEM). For ease of understanding this will be discussed in more 
detail in the section following the one on path analysis (which, it should be noted, is 
however generally considered as a technique in the SEM family).
2.3.3.1. Path analysis
Path analysis is a form of multivariate analysis which uses diagrams of postulated 
causal relationships between variables (“path diagrams”), and data collected by the 
researcher can then be tested to see if the pattern of variation observed in the data fits 
the postulated relationships. The relationships are postulated by the researcher, and 
are based on existing empirical data. The strengths of the relationships are provided 
by path coefficients (which are standardised beta coefficients). Path analysis can be 
used to test the accuracy of causal models for the sample collected. This has been 
termed an early form of SEM and uses observed variables in path analysis (as 
opposed to latent variables which are used in SEM -  see later). The advantages of 
path analysis include the following.
1) Explicit testing of collected data against postulated models encourages specific 
hypothesis formulation and avoids “fishing expeditions” where significant 
relationships are explained post-hoc and this can plague research on causation.
2) Direct and indirect effects of independent variables can be estimated.
3) There is simultaneous assessment of all relationships postulated and one can 
estimate direct and indirect effects on variables.
4) An estimate of how well the observed data fit the models can be made.
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To highlight the application of path analysis to the examination of data, a practical 
example is given in the appendix (Appendix 1).
An example of the type of path model specified for the analysis is given below
Seizure 
frequency 
at time 1
Depression 
scores at 
Time 1
Path analysis can also be applied to cross-sectional data. However only if longitudinal 
(panel) data are used can direction of effects be examined.
2.3.3.2. Structural equation modelling
2.3.3.2.I. What is structural equation modelling (SEM)?
SEM is a family of statistical techniques that enable the specified relationships 
between variables to be tested against the observed pattern of correlations and 
covariances between variables. Structural equation modelling represents an extension 
of path analysis (or alternatively path analysis represents a simple technique in the 
family of structural equation modelling) as it integrates factor analysis and path
Seizure 
frequency 
at Time 2
Depression 
at Time 2
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analysis into a single analytic framework (Joreskog & Sorbom, 2000). Cross-lagged 
panel analysis is a common method for analysing data using SEM.
2.3.3.2.2. Why was SEM used?
Structural equation modelling (SEM) has some important advantages (the comparison 
with path analysis is given at the end o f each point in italics):
1) It allows complete and simultaneous tests of all postulated relationships. This is 
widely accepted as being an especially suitable analytic method for longitudinal data 
when the phenomena of interest are complex and multifaceted (Tabachnick & Fidell. 
2001). This is also true ofpath analysis but SEM represents further elaboration o f  
these advantages and techniques.
2) Freedom from measurement error. When relationships between latent variables are 
tested, it allows the relationships to be examined free of measurement error. The error 
is estimated and removed and only the common variance is examined. This represents 
an advance over path analysis where the measurements are assumed to be assessed 
without error and as some error is inevitable this reduces reliability in path analysis. 
For SEM, measurement error is estimated and removed from the latent variable.
3) Flexibility. It is possible to simultaneously estimate the pattern of relations that 
exist between continuous and non-continuous measures when considered within the 
same theoretical model. In view of the combination of an ordinal variable (seizure 
frequency) with a continuous variable (depression) in the present study, the pre­
processing package PRELIS can generate a polyserial variance-covariance 
(correlation) matrix that takes into account differences in the measurement properties 
of each measure of seizure frequency and depression at each time point (also true o f 
path analysis).
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3) It facilitates formulation and testing of specific hypotheses based on empirical data. 
Alternative models can be tested and the provision of an estimate of model ‘fit’ 
(statistical estimate of the adequacy of a proposed theoretical model relative to the 
underlying pattern variance and covariance in the original data) allows testing of a 
postulated model against alternative models (this is also true o f path analysis)
2.3.3.3. Random effects latent variable modelling
The example given earlier is on cross-lagged panel analysis using a path model 
approach. As has been discussed in the introduction, what is not clear is how other 
psychological variables like anxiety and stress are associated with depression in 
affecting seizure activity. For this to be examined we used the second dataset which 
had measures of stress. However there were high stability levels for seizure activity 
which rendered the data less suitable for cross lagged panel analysis. This triggered a 
search for an alternative analytic technique which could be used on two time point 
panel data with variables displaying high stability levels and that allowed testing for 
moderation and mediation. Random effects latent variable modelling (Berrington 
et.al., 2006), using a structural equation modelling approach with LISREL 8.50 
(Joreskog & Sorbom, 2001) was decided on. In this context, the mean and variance of 
the latent variable represents the mean change over time of the group as a function of 
any given set of independent predictors (Berrington et.al., 2006; Ramos et.al., 2005), 
as compared to variation around the mean (as is the case in more conventional simple 
regression based approaches to data analysis) of a single indicator or measure of a 
dependent variable of interest.
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For this technique, measured seizure recency scores at different time points are 
indicators for a latent variable which will then represent “change in seizure recency 
score” (note this is a modelled change in score rather than a difference in raw scores) 
and is an estimate of true variance in seizure recency for the sample over the 5-month 
period considered (see Figure 1). The stability is essentially partialled out of this 
latent variable. Any relationship between this construct and an earlier assessed 
theoretical predictor (e.g., depression), represents the role of this predictor in 
accounting for variation or ‘change’ in seizure recency across the time frame 
considered in the study.
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Figure 2.3.3.3: An example of a random effects structural equation m odel.
Seizure recency at 
Time 1
rl Stress at I 
Time 1
T
N  V
Modelled Change ^
. Anxiety at I 
I Time 1
; Depression I 
at Time 1
“error”
“error”
Seizure recency at 
Time 2
n i i 1 1 « 1 1 1 1 1 1
Key to boxes & a rro w s
Independent/Predictor /exogen ou s m anifest (i.e. measured)variables
D ependent/ E ndogenous latent (i.e  unmeasured) variable
Dependent/ E ndogenous m anifest (i.e  measured) variables
From independent to dependent variables. (x=  path coefficient 
-standardised beta regression coefficients)
From dependent latent to dependent m anifest variables 
(y=factor loading/ pattern coefficient)
z/  \
z  = correlation coefficients
This method is very useful for examining variation in otherwise quite stable variables 
where there is information at two time points. If information is available from more 
than two time points the use of a latent growth curve model is recommended.
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2.3.3.4. Latent growth curve analysis (LGCA) or Latent growth curve 
modelling
LGCA has particular application to understanding individual variation in change in 
symptom scores during longitudinal studies. This is a powerful method of looking at 
change with individuals as we examine the role of predictors in predicting individual 
variation in responses.
Figure 2.3.3.4 Example of a latent growth curve model using SEM
Intercept
Mean baseline 
score
Variance of 
baseline score
Depression 
Time 1
Depression 
Time 2
Mean intra-individual 
variation
V a r ia n ce  o f  intra- 
2  in d iv id u a l 
v aria tion
Depression 
Time 3
residual residual residual
Seizure
recency
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2.3.3.4.1: Advantages o f latent growth curve modelling
1) Latent growth curve modelling allows examination of individual variation 
(intra-individual variation) in addition to group level variation (inter­
individual variation). This gives greater insight into processes which affect 
individuals.
2) Although LGCA makes the same assumptions regarding structure and 
properties of the data as for any regression analysis the analysis can also be 
carried out if these properties are relaxed. In particular, models can be tested 
when errors at different times are allowed to be correlated and also if there is 
heterogeneity of variance and the model fit can be used to see if there is any 
improvement in model fit under these conditions.
3) LGCA can be carried out with different assumptions about the type of changes 
in the data at different time points. For example growth in children is often 
non-linear (e.g. height during puberty shows a geometric increase). LGCA 
would allow this pattern of growth to be modelled and tested.
4) LGCA is more robust to variations from multivariate normality.
2.3.4. Assessment of model fit
One considerable advantage of using a structural equation modelling approach is that 
there are measures of how well data fit a postulated model. These can be used to 
compare alternative models. These are termed indices of model fit. There are several 
main indices used. Each index has its advantages and disadvantages. These are 
discussed next.
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Chi-squared test(/2 test)
This is commonly available and is easy to interpret. The aim for a “good” model is to 
find a non- significant chi-square test (as in this case the observed data are not 
significantly different from what is expected from the model). However the major 
disadvantage of the Chi-square test is that it is very sensitive to sample size. With 
large samples one can obtain high Chi-squared values (i.e. indicating a poor fit) even 
with trivial differences in model fit. It is also sensitive to departures from multivariate 
normality. It is important as it forms the basis of most of the other goodness of fit 
indices which however incorporate other adjustments making these less sensitive to 
sample size.
Root Mean Square o f  Approximation (RMSEA)
This has also been termed a parsimony adjusted goodness of fit index. It is a well 
regarded index because of several features (Kline, 2005). The first is that if there are 
two models with similar explanatory power for the same data, it will favour the 
simpler model. The second is that it does not assume a perfect fit between the data and 
the model. It uses the non-central chi-square distribution which rather measures the 
mis-specification of the proposed model (specifies a non-centrality parameter-5). If 
the value of 5 is zero, this is interpreted as indicating a central chi-square distribution 
and the null hypothesis is true. Higher values of 5 indicate more misspecification of 
the model.
Values of RMSEA of 0 indicate a perfect fit, values less than 0.05 a good fit, less 
than 0.08 a reasonable fit and >0.10 a poor fit. It is recommended that the 95% 
confidence intervals of this parameter are used. If one is <0.05 and the other <0.10
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this indicates a good fit. If any part of the confidence interval is >0.10 that indicates a 
poor fit.
Normed fit  index (NFI) and Non-normed fit index (NNFI)
This compares the chi-square value of the estimated model to the chi-square value of 
a fully independent model (i.e. where there is no association postulated). The values 
should be in the range 0-1. Good fitting models should have a value of 0.9 or higher. 
Unfortunately for small samples even good fitting models (using other indices) are 
sometimes “rejected” using this criterion. The non-normed fit index attempts to 
correct for this problem but for small samples, similar problems may remain and 
moreover the range of values can go outside the 0-1 range.
Confirmatory f it  index(CFI)
This assesses the fit of the estimated model to the independent model (i.e. where there 
is no association postulated) using the non-central chi-square distribution with non 
centrality parameters. If these are zero the fit is perfect.
The range of CFI values are between 0-1 and values greater than 0.95 indicate a good 
fit. The CFI is viewed by some as a good way of assessing model fit even for small 
samples (Tabachnick & Fidell, 2001).
Goodness o f Fit Index (GFI) and Adjusted Goodness o f Fit Index (AGFI)
This is an absolute fit index which can be thought of as similar to the squared multiple 
correlation (R2 ). It estimates the proportion of variability in the sample covariance 
matrix (covariance found in observed data) explained by the population covariance 
matrix (i.e. the covariance suggested by the hypothesised model). The normal range
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is zero to one, with a value of 1 showing a perfect fit (population covariance 
completely explained by sample covariance) and values of over 0.9 indicating a good 
fit. However just identified models can have values greater than 1 as can over 
identified models with perfect fit (Kline, 2005). The adjusted goodness of fit index 
developed to correct for model complexity, downwardly adjusts GFI scores with 
greater reduction for more complex models but scores above 1 are still an issue and 
computer simulation studies have shown some problems with the AGFI (Kline, 2005).
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Chapter 3
Do depression symptoms predict seizure 
frequency- or vice versa?
Citation
Thapar A, Roland M, Harold G. Do depression symptoms predict seizure frequency— 
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61
Abstract
Objective. To test a theoretical explanatory model of the relationship between 
depression symptom scores and seizure frequency in people with epilepsy.
Methods. A community based sample of adults with active epilepsy provided 
information on depression symptom scores and seizure frequency at two time points, 
one year apart.
Results. 1210 patients completed the initial questionnaire and 976 of these 
individuals (80.7%) completed the final questionnaire. Depression scores and seizure 
frequency were significant predictors of each other, both within time (p = .07, p <.05 
and p = .09, p <.05), and across time (P = .03, p <.01 and p = .07, p <.05). 
Conclusion. The relationship between depression symptom scores and seizure 
frequency in those with epilepsy is bi-directional.
3.1 Introduction
The association of increased seizure frequency with increased rates of depression is 
well established in cross-sectional community studies, with the assumption that it is 
poorly controlled epilepsy which is a major risk factor for depression in people with 
epilepsy in the community (Jacoby et.al., 1996, Ridsdale et.al., 1996). There is 
however increasing evidence from research of other chronic diseases, in particular 
ischaemic heart disease (Penninx et.al., 2001), diabetes (Talbot & Nouwen, 2000) and 
asthma (Mancuso et.al., 2001) that depression can predict the onset of physical 
diseases and influence outcome. Recent reviews of depression and epilepsy have also 
begun to suggest that the association arises as a result of bi-directional influences and 
have proposed a possible neurochemical basis for this relationship through specific 
neurotransmitter pathways (e.g. serotonin, noradrenaline, dopamine and GABA
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pathways) but have lamented the overall paucity of research in this area (Kanner, 
2003). To date, there have been two published studies of epilepsy that provide 
empirical support for the assertion that depression may precede epilepsy in adults. In 
these studies, depression was found to be a risk factor for the initial development of 
epilepsy (Forsgren & Nystrom, 1990; Hesdorffer et.al., 2000). However there is no 
information on whether depressive symptoms are predictive of seizure frequency for 
individuals with current epilepsy, that is affect the course of disorder in those with 
already diagnosed epilepsy. This information is important in that it has implications 
for the clinical management of people with epilepsy.
The aim of this study is to test a theoretical explanatory model of the relationship 
between depressive symptom scores and seizure frequency in people with epilepsy 
using a longitudinal study design.
3.2 Method
The sample included 1255 adults with active epilepsy (either a seizure recorded in the 
medical records in the last 2 years or currently on anticonvulsant medication for 
epilepsy) from a random selection of 82 general practices in Greater Manchester, U.K. 
who consented to participate. The sample had originally been recruited as part of a 
study to assess the effectiveness of an epilepsy prompt and reminder card in 
improving quality of care (Thapar et. al., 2002) in which there were three groups (a 
doctor-held card, a patient-held card and a control group; no group differences in 
patient rated outcome measures were found). All patients were sent questionnaires for 
self- completion. Seizure frequency from the Liverpool Quality of Life questionnaire 
(Baker et.al., 1993) and depression scores derived from the Hospital Anxiety and 
Depression Scale (HAD) (Zigmond & Snaith, 1983) were used in this analysis. Data
63
were collected at two time points 1 year apart. Seizure frequency is a self-report 
measure rated on the response to a question “How many epileptic attacks have you 
had in the past year” with the 3 response categories being “None”, “ Less than one a 
month” and “One or more a month”. Total scores on the HAD depression subscale 
range from 0 to 21. Both measures have been shown to have good reliability and 
validity (Baker et.al., 1993; Zigmond & Snaith, 1983).
Statistical methods
The aim of the study was to construct a theoretical explanatory model of the 
relationship between depression symptom scores and seizure frequency as they relate 
to each other across 2 time points and test how well the underlying observed data fit 
this model using structural equation modeling (SEM). Structural equation modeling 
represents an integrative statistical technique that combines factor analytic and path 
analytic traditions into a single data analytic framework (Joreskog & Sorbom, 2000). 
SEM confers a number of advantages over more traditional approaches to the analysis 
of correlational data. Principal among these is the simultaneous estimation of all 
parameters (pathways) and the provision of an estimate of model ‘fit’ (statistical 
estimate of the adequacy of a proposed theoretical model relative to the underlying 
pattern variance and covariance in the original data). SEM is also a very flexible data 
analytic package in that it is possible to simultaneously estimate the pattern of 
relations that exist between continuous and non-continuous measures when 
considered within the same theoretical model. In view of the combination of an 
ordinal variable (seizure frequency) with a continuous variable (depression) in the 
present study, the pre-processing package PRELIS was used to generate a polyserial 
variance-covariance (correlation) matrix that took into account differences in the
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measurement properties of each measure of seizure frequency and depression at each 
time point.
Cross-lagged and reciprocal models
Two sets of complimentary analyses were conducted. Firstly to assess the 
relationship between depression scores and seizure frequency across time, cross­
lagged models were tested whereby depression scores and seizure frequency at Time 
1 predicted each converse measure at Time 2, while controlling for the stability 
between depression scores and seizure frequency across time (see Figure 1, Page 74). 
Secondly to assess the relationship between seizure frequency and depression scores 
within time, a reciprocal effects model was tested whereby depression scores and 
seizure frequency rates simultaneously predicted levels of each variable at Time 2, 
again having controlled for the stability of depression scores and seizure frequency 
across time (see Figure 2, Page 74).
Assessment o f model f i t
The statistical adequacy of a theoretical model is determined by the relative ‘fit’ of 
that model to the underlying pattern of variances and covariance (correlations) 
observed in the original data. Assessment of fit is determined by the estimation of a 
number of goodness-of-fit criteria provided by the SEM programme LISREL. A good 
model would have a non significant chi-square (x2) value, a root mean square error of 
approximation (RMSEA) less than 0.05, a goodness of fit index(GFI) of > 0.9 and an 
adjusted GFI of > 0.9.
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3.3 Results
Sample characteristics
1210 patients completed the initial questionnaire and 976 of these individuals 
(80.7%) completed the final questionnaire 1 year later. At the start of the study 11.6% 
of individuals had scores in the range suggestive of clinical depression and 50.7% of 
individuals had been seizure free over the previous year. At the end of the study 
12.9% of individuals scored in the range suggestive of clinical depression and 55.2% 
of individuals had been seizure free in the previous year. The mean age of participants 
was 49.6 years and 21% of participants were over the age of 65 years. The sample 
characteristics are summarised in Table l(Page 75).
Results from structural equation modelling
Figure l(Page 74) shows the standardised path coefficients for cross-lagged tests of 
relations between seizure frequency and depressive symptom scores for the full 
sample. As expected, the stability coefficients between each measure over time were 
strong and significant (seizure frequency, P = .87, p <.01; depressive symptoms, p = 
.71, p < .01). Despite this high stability, in addition, significant paths between seizure 
frequency at Time 1 and depressive symptoms at Time 2 (p = .07, p <.05), and 
depressive symptoms at Time 1 and seizure frequency at Time 2 (P = .03, p <.01) 
were identified. Each measure at Time 1, therefore, significantly predicts a ‘change’ 
in the level of the other measure at Time 2, emphasising the mutual importance of 
these measures to each other across time. To test whether this same pattern of 
relations existed in the data within time, a reciprocal effects model was tested.
Results presented in Figure 2 (Page 74) show that, once again, a significant reciprocal 
relationship exists between seizure frequency and depressive symptoms (p = .09, p
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<.05) and depressive symptoms and seizure frequency (P = .07, p <.05) at Time 2, 
when variable levels were statistically controlled across time (seizure frequency, p = 
.86, p <.01; depressive symptoms, P = .70, p <.01). Because the cross-lagged model 
is a fully saturated model (i.e., all unknown parameters relative to degrees of freedom 
are estimated), this model art factually provides a perfect ‘fit’ to the data. The 
reciprocal effects model provides one degree of freedom, thereby permitting an 
assessment of model fit. According to statistical criteria, this model provides an 
excellent ‘fit’ to the data (x2, = 1.39, GFI = 1.0, AGFI = 0.99, RMSEA = 0.02).
It has been suggested that depression scores should be categorised into “not 
depressed”, “doubtful depression” and “definite depression”. This will result in an 
identical variable type (3-category variables) for both variables (depression and 
seizure frequency). The cross lagged and reciprocal models were re-run using 
categorised depression scores. The results were very similar and the same 
conclusions were reached i.e. seizure frequency and depressive symptoms reciprocally 
influence each other within and across time.
3.4 Discussion
The results of this study suggest that depressive symptom scores and seizure 
frequency mutually influence each other concurrently and across time, having 
controlled for initial symptom scores and seizure frequency in both sets of analyses.
It is widely accepted that how many seizures an individual has will have 
psychological sequelae. The pattern of relations found in this study suggests that 
depression symptoms have equally important influences on future seizure frequency. 
There is limited research examining the relationship between depression and seizure
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frequency. Most research has focused on examining the relationship of type of 
epilepsy to depression. Larger scale, community based research has been cross 
sectional and assumed a unidirectional relationship in which seizure frequency 
influences depression although cross-sectional designs do not allow for testing 
direction of influence (Jacoby et.al., 1996, Ridsdale et.al., 1996; O’Donaghue et.al.,
1999). Other community-based studies of epilepsy have targeted seizure reduction as 
the key method for improving quality of life (Birbeck et.al., 2002). The findings of 
this study suggest that focusing on treating depression in people with epilepsy is as 
important.
To date, there has been virtually no research testing the extent to which depression 
affects seizures. There is limited evidence from small, uncontrolled studies, however, 
that antidepressant treatment of depression improves seizure control (Ojemann et.al.,
1983). Existing longitudinal studies have focused on whether or not depression 
precedes the onset of epilepsy and found that depression may be a risk factor for 
epilepsy in adults (Forsgren & Nystrom, 1990; Hesdorffer et.al., 2000) and children 
(Hesdorffer et.al., 1998). Overall, these findings, taken together with the results from 
our own study highlight that it is not safe to assume that the association of epilepsy 
and depression arises from the unidirectional effects of seizures.
So what could account for our finding that depression scores predict seizure 
frequency? A neurochemical basis has been proposed based on empirical evidence 
(Kanner, 2003) but this is difficult to test. However psychosocial factors, such as self- 
efficacy and social support that are associated with chronic disease severity and 
depression (Amir et.al., 1999), also could be important mediating mechanisms. Other 
potential mediators include treatment compliance and other aspects of self-care that
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are affected by depression and that may then impact on seizure control. Finally, the 
relationship between depression and epilepsy may be explained by a common set of 
aetiological factors.
The bi-directionality of the relationship between depression and other chronic 
illnesses has increasingly become an area of interest. For diabetes there is evidence 
that depressive symptoms are associated with glycaemic control (Mazze et.al., 1984), 
that depression precedes diabetes (Eaton et.al., 1996) and that the treatment of 
depression improves glycaemic control (Lustman et.al., 1998). Depressive symptoms 
have also been found to predict outcomes in asthma (Mancuso et.al., 2001) and heart 
disease (Penninx et.al., 2001). Thus, there is an increasing body of evidence 
implicating the importance of depression in predicting chronic disease outcomes. This 
has implications in terms of how chronic diseases are managed. Our results in a large 
sample of people with epilepsy when considered in the context of findings for other 
chronic diseases suggest that reducing levels of depressive symptoms may be an 
important component of clinical management in terms of seizure control. This now 
needs to be tested in a controlled intervention study. Furthermore, given that 
depression rates for people with epilepsy are higher than for the general population, it 
is important to examine whether antidepressants are under-prescribed. Antidepressant 
use in epilepsy may be affected by a perception amongst health professionals and 
patients that antidepressants worsen seizure control (although this was a risk with 
older antidepressants, newer antidepressants do not carry this risk).
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The main strengths of this study are that a large number of representative adults with 
epilepsy in the community were assessed using well-validated and reliable measures 
and that a powerful analytic tool, structural equation modeling was used to test 
relationships.
There are also potential weaknesses of this study however. Firstly, not all individuals 
who commenced the study completed the study (19% of individuals who completed 
the first questionnaire did not complete the second questionnaire). Secondly, an 
ordinal measure of seizure frequency was used. However, polychoric correlation 
matrices were derived and these facilitate analysis of both continuous (depression 
scores) and non-continuous (seizure frequency) measures while adhering to the 
important assumption of multivariate normality. Thirdly, self-report measures had to 
be used and this could have influenced findings. However, using other informants in a 
large-scale community-based study was not feasible and at present little is known on 
the validity of information on seizure frequency and depression provided by other 
informants.
Two other factors which need to be taken into account are measurement time frames 
and the influence of seizure type. Depression and seizure frequency measures do not 
reflect information from exactly the same point in time (seizure frequency is 
measured over the past year and depression scores refer to the past week). However 
there is high stability of both seizure frequency and depression scores and moreover 
the overall effect is likely to underestimate cross-lagged and reciprocal path 
coefficients rather than overestimate them. Secondly, previous research has suggested 
that individuals with partial epilepsy are more likely to be depressed (but findings
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have been mixed) (Indaco et.al., 1992). The sample size for individual seizure types 
was not large enough to run structural equation models for each seizure type but in a 
regression analysis, using seizure types as independent variables, only a history of 
tonic-clonic seizures significantly predicted depression scores. Moreover the closest 
association between seizure frequency and depression scores was found for 
individuals with tonic -clonic seizures (these results are available from the first 
author). This will be important to further investigate in future research.
Finally, while the results in the present study suggest a statistically significant 
reciprocal relationship exists between seizure frequency and depressive symptoms, an 
important question is how clinically significant these findings are. Interpretation of 
the results needs some discussion of the methodology and further explanation of 
structural equation modeling. The results are from a study the main aim of which was 
to improve recording of clinical information. Depression scores and seizure frequency 
were not significantly altered during the course of the study. These findings are 
reflected in the high stability for depression scores and seizure frequency. This will 
result in low levels of unexplained variance in each respective dependent 
(endogenous) measure. Thus statistically significant cross-lagged paths will be 
difficult to detect, even with large sample sizes, given that relatively few individuals 
changed depression or seizure status spontaneously and these path coefficients will 
therefore necessarily be low. These path coefficients should not be equated with 
regression coefficients obtained by standard regression analysis. In structural equation 
modelling, all paths in a given model are estimated simultaneously and thus, given the 
stability of measures over time, there is little remaining unexplained variance and thus 
the magnitude of other standardised path coefficients will seem low to those more
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familiar with regression coefficients. However, it is important to highlight that these 
pathways are accounting for a significant proportion of variance in each respective 
dependent (endogenous) variable over and above that accounted for the stability 
between measures.
Cross-lagged stability models allow examination of relations between constructs (in 
this paper, depression and seizure frequency) while controlling for their stability. 
Significant cross-lagged effects reflect the presence of a directional relationship 
between constructs. These cross-lagged effects are beyond that which can be 
accounted for by the stability of depression and seizure frequency across time and the 
magnitude of their association at Time 1. To examine possible bi-directional 
relationships between constructs within time, non-recursive or reciprocal effects 
models are used and are appropriate. For a bi-directional model to be identified (i.e., 
mathematically estimable), several conditions need to be met. The present model (see 
Figure 2) satisfies these conditions in that earlier measures of seizure frequency and 
depressive mood are predetermined variables and thereby uncorrelated with the error 
terms in both Time 2 equations, and both cross-lagged effects are constrained to zero. 
Analyzing correlational data using cross-lagged and reciprocal effects models, in the 
way that has been undertaken in this study, is an extremely important and robust 
method of investigating whether changes in one variable predict later changes in 
another variable and testing hypotheses representing different explanatory models of 
the relationships between variables. This is an essential first step prior to designing 
intervention studies (MRC, 2000) that can then be used to further address questions of 
cause and effect.
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In summary, in a large, longitudinal community based study of people with epilepsy, 
depression symptoms were found to influence seizure frequency and vice versa, cross- 
sectionally and over the period of one year. This has important implications in terms 
of understanding the origins of the association between depression and seizure 
frequency and in how epilepsy is clinically managed. The results also add to the 
increasing literature on the important influence of depression on the onset and 
outcomes of chronic physical diseases.
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Figure 1: Cross-lagged path model for seizure frequency and depressive
symptoms
0.87**
0.07*
0.03*
0.71**
Seizure 
frequency 
(Time 1)
Depression 
score 
(Time 2)
Seizure 
frequency 
(Time 2) ^
Depression 
score 
(Time 1)
1 C , =  error variance for this variable 
* p<0.05
**p<0.01
Figure 2: Reciprocal path model for seizure frequency and depressive symptoms
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Table 1 :Sample characteristics
Age (n=1210) Years (standard deviation)
Mean age 49.6(17.3)
Age groups (years) n(%)
20 or under 41 (3.4)
21-30 164(13.6)
31-50 430 (35.5)
51-65 321 (26.5)
>65 254 (21.0)
Sex (n=1209) n(%)
Male 580 (48.0)
Female 629 (52.0)
Seizure type (n=596) n (%.).May have more than one seizure type and so % 
will add up to more than 100%)
Generalized: tonic—clonic 332 (55.7)
Partial: simple 28 (4.7)
Partial: complex 182 (30.5)
Others, including absence 
seizures
220 (36.9)
Family history (n=955) n (%)
Yes 97(10.2)
No 858 (89.8)
Seizure frequency Time 1 (n=U97), n (%) Time 2 (n=954), n (%)
No seizures in the last year 607 (50.7) 527 (55.2)
Less than 1 Seizure/month 261 (21.8) 194 (20.3)
One or more seizure per 
month
329 (27.5) 233 (24.4)
Depression scores Time 1 (n—1185), mean 
(S.D.)
Time 2 (n=959),mean 
<SD.)..... ............... ...........
Total score 5.34 (3.8) 5.37 (4.0)
Categorized depression 
scores
Time 1, n (%) Time 2, n (%)
“No depression” (0 -7) 878 (74.1) 694 (72.4)
“Doubtful depression” (8 -  
10)
170(14.3) 141 (14.7)
“Definite depression” (11— 
21)
137(11.6) 124(12.9)
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Abstract
Objective: The goal of the study described here was to examine the interrelationship 
between psychological factors (anxiety, stress, and depression) and seizures. 
Methods: In this longitudinal cohort study, data on anxiety, depression, perceived 
stress, and seizure recency (time since last seizure) and frequency were collected at 
two time points using standard validated questionnaire measures. Empirically based 
models with psychological factors explaining change in (1) seizure recency and (2) 
seizure frequency scores across time were specified. We then tested how these 
psychological factors acted together in predicting seizure recency and frequency. The 
data were used to test whether these models were valid for the study population. 
Latent variable structural equation modeling was used for the analysis.
Results: Four hundred and thirty-three of the 564 individuals who initially consented 
to participate provided two waves of data for this analysis. Stress (p = 0.25, p < 0.01), 
anxiety (p = 0.30, p < 0.01), and depression (p = 0.30, p < 0.01) all predicted change 
in seizure recency. However, it was depression that mediated the 
relationship of both anxiety and stress with modelled change in seizure recency (p =
0.19, p < 0.01) and seizure frequency (p = 0.30, p < 0.01) over time.
Conclusion: Depression mediates the relationship between stress and anxiety and 
change in seizure recency and seizure frequency. These findings highlight the 
importance of depression management in addition to seizure management in the 
assessment and treatment of epilepsy in an adult population.
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4.1 Introduction
Depression and epilepsy appear to be closely associated (Kanner et.al., 2005). 
Depression is considerably more prevalent amongst people with epilepsy as compared 
to the general population (Strine et.al., 2005) with people with poorly controlled 
epilepsy especially reporting higher rates of depression (Jacoby et.al., 1996). The 
nature of the association is however complex. There is some evidence that the 
relationship between seizure onset and depression onset is bidirectional (Kanner,
2005) with diagnosis of epilepsy acting as a risk factor for the onset of depression and 
depression acting as a risk factor for the onset of epilepsy (Hesdorffer et.al., 2000). 
There is emerging evidence that this bidirectional relationship between depression and 
seizures is also evident for those with current epilepsy (Thapar et.al, 2005). However 
other psychological problems such as anxiety (Beyenburg et.al., 2005; Mensah et.al, 
2007) and stress (Frucht et.al., 2000) are also reported to be more prevalent amongst 
people with epilepsy but have been less studied (Beyenburg et.al, 2005). How these 
psychological factors act together to influence seizures is not clear.
In the general population it is well established that stress, anxiety and depression are 
closely linked (Hettema et.al., 2006) although for complex disorders inter­
relationships are likely to be complex (Kraemer et.al., 2001). Anxiety and stress 
appear to precede depression (Kendler et.al, 2002; Kendler et.al, 2006). The strong 
links between anxiety, stress and depression are also supported by neurobiological 
research (De Kloet et.al, 2005; Nemeroff & Vale, 2005; Heilig, 2004) and neuro­
imaging studies (Liotti et.al, 2000; Sapolsky, 2000, Shah et.al, 2002; Kalisch et.al,
2006).
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Thus for people with epilepsy, anxiety and stress may also contribute to the 
previously observed links between depression and seizures. People with epilepsy 
perceive that stress is the most common precipitant for seizures (Frucht et.al., 2000) 
and in community studies, anxiety is the most common psychological problem 
amongst people with epilepsy (Beyenburg et.al., 2005). Anxiety may also be linked to 
poor seizure control and more recent seizures (Mensah et.al, 2007). However, 
although associations between these individual factors have been observed, the nature 
of the overall relationship between depression, stress and anxiety with seizures 
remains poorly understood (Haut et.al, 2007) and previous studies have been cross 
sectional. Longitudinal studies are important in establishing the directions of 
influence between different factors (Rutter, 2008).
The aims of this analysis were to test how psychological factors (depression, anxiety 
and stress) predict variation in 1) seizure recency and 2) seizure frequency over time.
4.2 Methodology
Sample
A cohort of adults with active epilepsy was recruited to participate in a longitudinal 
observational study of the physical, social and psychological health of people with 
epilepsy. Individuals identified through general practices who had taken part in 
previous studies in Cardiff (Mensah et.al, 2006) and Manchester (Thapar et.al., 2002) 
were contacted and invited to participate in the present study. Ethical approval was 
obtained from the relevant local Research Ethics Committees (BroTaf and Salford & 
Trafford). A volunteer sample of people with epilepsy was also recruited through
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Epilepsy Action. Participants were sent questionnaires by post for self-completion 
and information was collected at two time points 5 months apart.
Measures
Participants completed a comprehensive package of well-known and validated 
measures of physical, social and psychological health.
The following subset of measures was employed in the present study:
1. Anxiety and Depression. The Hospital Anxiety and Depression (HAD) scale was 
used (Zigmond & Snaith, 1983). This is a widely used measure with good 
psychometric properties which has been successfully used to measure caseness for 
depression and anxiety in previous community based studies examining the quality of 
life of people with epilepsy (Jacoby et.al., 1996). It refers to how the respondent has 
been feeling in the past week.
2. Perceived stress. The 4 item perceived stress scale PSS (Cohen et.al., 1983) was 
used as a measure of stress. It refers to perceived stress levels in the past month i.e. is 
a measure of stress appraisal. The 4 item scale was used to minimise respondent 
burden. It has been found to have acceptable psychometric properties (Cohen et.al., 
1983) and has been used in previous outpatient and community studies (Farabaugh 
et.al., 2004).
3. Seizure recency. (Wagner et.al., 1995; Cramer et.al, 2004). Participants were 
asked how long it had been since they had their last seizure. This measure has been 
used in previous studies (Cramer et.al, 2004). The responses were converted to days 
since last seizure and categorised. A 12 category variable was created with scores 
ranging from 12 (seizure in the last 24 hours) to 1 (last seizure was more than 15 years
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ago) with a midpoint score of 6 (last seizure was between 6 and 12 months ago) i.e. 
with the most recent seizures having the highest scores. Categorization was used for 
conceptual and clinical reasons as well as to overcome problems with model 
convergence.
4. Seizure frequency. Individuals were also asked about the number of seizures they 
had experienced over the previous year with scores ranging from 0 (if the individual 
had had no seizures) to 10 (if the individual had 10 or more seizures) in the previous 
year.
5. Medication compliance. Individuals were also asked to rate how often they missed 
any medication for their epilepsy at the end of the study. Responses were on a 4 point 
Likert Scale -  ranged from 1= “never” to 4= “missed doses more than once a week”.
Statistical analysis
Random effects latent variable modelling (Berrington et.al., 2006), using a structural 
equation modelling approach with LISREL 8.50 (Joreskog & Sorbom, 2001) was 
used for this analysis. Structural equation modelling (SEM) was used for the analysis 
as it allows complete and simultaneous tests of all postulated relationships and is 
widely accepted as being an especially suitable analytic method for longitudinal data 
when the phenomena of interest are complex and multifaceted (Tabachnick & Fidell, 
2001). SEM is a family of statistical techniques that enable the specified relationships 
between variables to be tested against the observed pattern of correlations and 
covariances between variables. This allows an assessment of whether or not the 
hypothesized relationships are valid for the study population. This approach has 
considerable advantages over simple regression based analysis when longitudinal data 
are available as it is possible to specify a latent variable model such that ‘change’ in
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the criterion variable can be modelled as a result of one or more theoretically relevant 
predictors (Berrington et.al., 2006).
In this context the mean and variance of the latent variable represents the mean 
change over time of the group as a function of any given set of independent predictors 
(Berrington et.al., 2006; Ramos et.al, 2005), as compared to variation around the 
mean (as is the case in more conventional simple regression based approaches to data 
analysis) of a single indicator or measure of a dependent variable of interest. We then 
tested predictors firstly for modelled change in seizure recency (see Figure 1, Page 
94) then for modelled change in depression scores over time.
Analyses were carried out as follows. Models were specified for 1) Depression, 
anxiety and stress predicting change in seizure recency 2) Depression, anxiety and 
stress predicting change in seizure frequency 3) Other analyses (included tests for 
moderation and a model predicting change in depression scores).
4.3 Results
564 individuals initially consented to participate. Of these individuals 341 were 
recruited from Cardiff, 108 from Manchester and 115 via Epilepsy Action. 468 
individuals responded to first wave questionnaires and 443 individuals responded to 
second wave questionnaires.
Some individuals missed items on particular scales. A two-step approach was used to 
deal with missing values. First, for partially completed scales, regression-based 
imputation methods for missing data were used (standard missing values procedure in
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STATA Version 8). Means (SD) of all variables used in this analysis for both non­
imputed and imputed untransformed scores are listed in Table 1 (Page 96). Second, 
list wise deletion of data was undertaken prior to the structural equation modeling 
analyses such that only individuals with complete information for all variables were 
included in all subsequent analysis.
We examined whether our sample was representative in terms of epilepsy severity and 
socio-demographic characteristics. Our findings were comparable to findings from a 
large community based study of adults with epilepsy (Jacoby et. al., 1996). We also 
examined seizure types and anti-convulsant medication use and the effects of these 
parameters on depression scores. The main comparisons are listed in Table 2 (page 
96). Significantly higher depression scores were reported by individuals who 
reported they had suffered from complex partial seizures (F=12.78, p <0.01) and 
myoclonic seizures (F=6.28, p=0.013) than those who reported not having these 
seizure types. For other seizure types there were no significant differences between 
those who had had and those who had not had that particular seizure type. There were 
no significant differences in depression scores associated with anti-convulsant 
medication.
One quarter of our sample suffered from seizures at least once a month. These 
individuals were more likely 1) to suffer from complex partial seizures; 43.6% (versus 
6 .5% of those who were seizure free) reported complex partial seizures were their 
main type of seizure (this difference was significant) and 2) to be scoring as clinically 
depressed (10.9% versus 4.4% of those who were seizure free).
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The data were also transformed; anxiety and depression scores were negatively 
skewed so were transformed using a square root (raw score+1) transformation. 
Analyses were carried out on transformed data.
The rounded mean score for seizure recency for all three waves was 6 (6.18, 5.84, 
5.96, 6= “last seizure between 6 and 12 months ago”), the modal score was 3 for all 
three waves (“last seizure between 5 and 10 years ago”) and the median score was 6 
for the first wave and 5 (’’last seizure between 1 and 2 years ago”) for the second 
wave.
There was a significant difference in terms of seizure recency between groups of 
individuals recruited from Cardiff, Manchester and from Epilepsy Action (Pearson %2 
(4) = 29.95, p = <0.01). Individuals recruited from Manchester and Cardiff had a 
similar seizure recency (Pearson %2(2) = 1.24, p=0.54) and these groups were 
combined for subsequent analyses. Individuals recruited via the British Epilepsy 
Association (Epilepsy Action) had significantly more severe epilepsy (i.e. a higher 
proportion of recent seizures) than the combined Cardiff/Manchester subgroup. To 
accommodate this initial heterogeneity in the sample the main analysis was performed 
separately for each of these two subgroups.
Generally high stability values were noted (figures in brackets represent correlation 
coefficients) for seizure recency (0.81), anxiety (0.81), depression (0.78), and 
perceived stress (0.59) between the two time points. Acceptable reliability values for 
all scales used in the analyses were obtained (figures in brackets represent Cronbach’s
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alpha values) for PSS (Time 1= 0.76 Time 2 = 0.70), depression score (Time 1 = 0.77, 
Time 2 = 0.81), anxiety score: (Time 1= 0.88, Time 2 = 0.87).
Depression, anxiety and stress predicting change in seizure recency 
Structural equation modelling was used to test models with each of the individual 
psychological variables (stress, anxiety and depression) and modelled change in 
seizure recency score over time. All three models showed a good fit and all three 
psychological variables (anxiety scores (P=0.30, p<0.01), stress (p=0.25, p<0.01). and 
depression scores (P = 0.30, p<0.01)), were individually significant predictors of the 
latent change in seizure recency score over time.
A full model was then specified in which stress, anxiety and depression were 
simultaneously specified as predictors for the modelled change in seizure recency 
score over time (Figure 2, Page 95). When the psychological variables were analysed 
simultaneously, depression was the only significant predictor for modelled change in 
seizure recency over time. All the model fit indices indicated a good fit of the data to 
the model (N= 395 3^ = 0.16; DF=2 p=0.92; RMSEA = 0.0 AGFI= 1.00; CFI =1.00 
SRMR=0.0015). There was an increase in the R (that is explained variance) of the 
modelled change in seizure recency with additional predictors. If there was only one 
predictor the R2 value ranged from 0.06 (stress) to 0.09 (depression, anxiety). If stress 
and anxiety were predictors then the R value was 0.10. With all three predictors the 
R2 value was 0.12.
This model was also run for each of the two sub-groups identified earlier (as initial 
sample heterogeneity had been noted). Identical conclusions were reached with
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similar results (i.e. only depression was a significant predictor of modelled change in 
seizure recency over time (p <0.05 for both groups) and neither anxiety nor stress 
were significant predictors.
Depression, anxiety and stress predicting change in seizure frequency 
The analysis was also run for the full model in which stress, anxiety and depression 
were specified as predictors for modelled change in seizure frequency score over time. 
The results confirmed the findings for recency, that is, depression mediated the 
relationship between anxiety and stress with change in seizure frequency over time 
(t=4.65, p<0.01). The model fit indices generally indicated an acceptable fit of the 
data to the model (N= 386 %2= 7.62; DF=2 p=0.02; RMSEA = 0.085 AGFI= 0.94, CFI 
=1.00, SRMR=0.0072).
Other analyses
Testing fo r interaction effects between psychological factors 
Having tested for additive effect of the psychological factors on seizure recency, we 
next tested for interaction effects between psychological factors. A model was 
specified in which depression, stress and the interaction term between depression and 
stress were predictors for modelled change in seizure recency over time. There was no 
significant effect of the interaction term on modelled change in seizure recency (t= - 
1.07, p =-0.05, p = NS). Similar results were obtained for the interaction term 
between anxiety and depression and for the interaction term between anxiety and 
stress.
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Testing for the relationship between anxiety, stress and seizures 
When anxiety and stress were specified as predictors for modelled change in seizure 
recency, only anxiety (p= 0.24, p < 0.01) was a significant predictor (stress P = 0.10, 
p= NS). The fit statistics across all models tested suggested that each model provided 
a good fit to the data. % ranged from 0.02- 2.3 (degrees of freedom ranged from 1 to 
2).
Non-adherence with medication
We also examined non-adherence rates and tested if self -reported non-adherence was 
linked to seizure recency, depression, anxiety or stress. 69.7% (363) of our sample 
who returned questionnaires at the end of the study reported that they did not miss any 
medication doses. Increased perceived stress was the only factor significantly 
associated with higher frequency of non adherence (n=363, r=-0.108, p=0.04).
Predictors o f modelled change in depression scores
Finally, given previous research suggesting the bidirectional relationship between 
depression and seizures, we also specified a model in which seizure recency, anxiety 
and stress were predictors for modelled change in depression scores over time and we 
found that all three variable were significant predictors of change in depression scores 
(anxiety scores (p=0.47, p < 0.01), stress (p=0.21, p < 0.01). and seizure recency (P =
0 .12, p < 0.01)). There was no evidence of mediation or moderation. Fit statistics 
suggest that the model provided an adequate fit to the data (x2 (2) =11.24, p=0.004 
RMSEA = 0.11 AGFI= 0.92, CFI =0.99, SRMR=0.018).
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4.4 Discussion
The aim of this paper was to gain additional insights into the mechanisms underlying 
the relationship between anxiety, stress and depression with seizures using the results 
from a longitudinal community based observational study of people with epilepsy.
Findings suggest that depression, anxiety and stress when analysed separately, 
predicted variation in seizure recency over time. However, depression mediated the 
relationship between anxiety and perceived stress with variation in seizure recency 
over time. Further analysis confirmed the same pattern of results for variation in 
seizure frequency over time. There was no evidence for any moderated relationships. 
Thus, depression appears to be the important pathway in linking the psychological 
variables we assessed to change in seizure activity.
People with epilepsy perceive stress as being the most likely trigger for a seizure 
(Frucht et.al., 2000). Certainly stress is implicated in increased activity in neural 
circuits which affect a wide range of brain regions, in regulation of neurotransmitter 
pathways implicated in epilepsy as well as neuroendocrine changes (Nemeroff & 
Vale, 2005), gene expression and structural and functional brain changes (Geuze et.al, 
2005). We used a measure of stress appraisal (the 4 item perceived stress scale- PSS) 
for our analysis as the closest psychometrically tested variable that approximated in 
meaning to “stress” that had been used in other studies which had reported on the 
perceptions of individuals as to the trigger for their seizures. The implications of 
stress appraisal (using the 10 item version of the same scale) on common diseases 
have recently been highlighted (Cohen et.al., 2007). Our results suggested that whilst 
stress appraisal did seem to predict the variation in seizure recency over time, this
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relationship was mediated by depression. This is in line with a classic research study 
in a general population sample that found negative affectivity affects the relationship 
between stress and health (Watson & Pennebaker, 1989) and highlights the 
importance of screening for depression if an individual with epilepsy reports high 
levels of stress. There was no evidence for stress appraisal playing a moderator role in 
the relationship between depression scores and variation in seizure recency over time.
The relationship between anxiety and seizures is relatively under-researched 
(Beyenburg et.al., 2005). There is some evidence from the general psychiatric 
literature that anxiety symptoms are a precursor for depression (Hettema et.al, 2006; 
Merikangas et.al., 2003) and share the same genetic liability (Rice et.al, 2004). In our 
study we found that anxiety predicted variation in seizure recency but that this 
relationship was mediated via depression, that is that anxiety appeared to exert risk 
effects through depression. The distinction between anxiety and depression is also 
important in terms of clinical management guidance suggesting first line 
psychological intervention for individuals with clinical anxiety (NICE CG22, 2004) 
and pharmacological (anti-depressant medication) interventions for those with clinical 
depression, apart from those with mild depression (NICE CG23, 2004). Our analysis 
also provided some evidence that anxiety partially mediates the relationship between 
stress and depression. The importance of identifying the exact pattern of 
psychopathology has been highlighted (Kraemer et.al, 2001, Kraemer et.al., 2002; 
Mayberg, 2007). Our findings are in line with the scientific literature on the links 
between stress and depression (De Kloet et.al, 2005, McEwen, 2003) which have 
highlighted the progressive and more severe nature of neurobiological impairment in
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depression (than in stress) and the neurobiological dysfunction in epilepsy. However 
caution is needed with any observational study on direction of association.
Our study highlighted the importance of depression in variation in seizure recency 
over time but also confirmed that seizure recency can predict variation in depression 
scores over time. A study using a different dataset has confirmed this bi-directional 
relationship between depression scores and seizure frequency in those with current 
epilepsy (Thapar et.al, 2005). The mechanism for the effect of recent seizures on 
long term depression scores could either be through a direct neurobiological change 
(Kanner, 2005) and this would be supported by findings that depression is a risk factor 
for the onset of epilepsy (Hesdorffer et.al, 2000, Hesdorffer et.al., 2006). However 
the links between seizures and depression could also arise through other mechanisms 
such as life disruption or negative emotions which could manifest itself on behaviour 
changes such as changes in compliance with medication or by engaging in other risky 
behaviours such as increasing alcohol intake. Non-compliance with medication has 
been linked to poor seizure control (Cramer et.al, 2002) and this link may be 
explained by high anxiety levels (Jones et.al., 2006). The exact mechanisms 
underlying this relationship are unclear. Links between depression and non- 
compliance for other conditions such as coronary heart disease (Gehi et.al, 2005) and 
diabetes (Lin et.al, 2004) have been found. In our sample however there was no 
evidence of association of depression or anxiety scores and severity of non- 
compliance but individuals with higher perceived stress scores reported a higher 
frequency of non-compliance.
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In our study the same pattern was found for modelled change in seizure recency as for 
modelled change in seizure frequency, i.e. depression mediated the relationship 
between anxiety and stress and seizure activity. In the epilepsy literature the choice of 
outcome variables for seizure activity has been highlighted (Baker et.al., 1998). Both 
seizure frequency and seizure recency have been used, generally in the context of 
predicting quality of life (QOL). The findings have been mixed with one study 
reporting that seizure frequency but not seizure recency significantly predicts QOL 
(Leidy et.al, 1999) but another study finding that both seizure frequency and seizure 
recency are significant predictors of QOL (Mrabet et.al, 2004). The results of the 
National General Practice Study of Epilepsy found that psychosocial effects was 
highly significantly associated with seizure recency and total number of seizures 
experienced (Chaplin et.al., 2002)
Our sample was similar to that from other community based studies in terms of 
seizure frequency, mean age, gender and predominant seizure type (Jacoby et.al,
1996; Ettingeret.al., 2004) as well as for medication use (Goodwin et. al, 2002). In 
accordance with the findings of other studies higher depression scores were found 
amongst individuals who suffered from complex partial seizures and more frequent 
seizures (Jacoby et.al., 1996).
The method used for the principal statistical analysis has a strong theoretical 
underpinning (Berrington et.al., 2006) although it has not been as widely used as cross 
lagged panel models in SEM or latent growth curve analysis.
91
We used a variety of recruitment methods for our study. Our sample however was 
representative in terms of overall disease severity and socio-demographic 
characteristics when compared to another large community based study of adults with 
epilepsy (see Table 1, Page 96).
Limitations
Not all individuals completed all two waves of questionnaires and not all individuals 
who completed questionnaires completed all the different sections. However, more 
than 80% of individuals who had consented to participate and who had not died or 
withdrawn at the first questionnaire stage completed the second questionnaire. A 
further limitation is that the measures refer to different periods (PSS “ past 1 month,” 
depression “ over the last week”). High stability values for the variables were noted 
(Table 1, Page 96), which would suggest that these results could reasonably be 
extrapolated outside these periods. Some individuals have infrequent seizures and 
many had not had a seizure over the study period. We would, however, expect this to 
lead to an underestimate of the effect of seizures. This study was designed to examine 
relatively long-term (5 months) prediction of variation in seizure recency. We are not 
able to extrapolate our findings to whether there are short-term effects of these 
variables (e.g., effects of a single episode of stress on triggering a seizure). To 
examine these effects, a different study design such as a daily seizure diary method 
would have to be employed. A further potential limitation was introduced by the fact 
that seizure variables are complex and heterogeneous. There are a variety of ways to 
capture seizure activity and impact, such as seizure frequency, seizure recency, and 
seizure severity, and moreover, variation is introduced by different types of seizures. 
We have reported results for both seizure frequency and seizure recency as outcome
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variables, and the results were unchanged. There were not enough individuals for the 
analysis to be carried out for different seizure types.
In conclusion, although perceived stress and anxiety symptoms predict variation in 
seizure recency over time, this relationship is mediated by depression symptoms. It is 
important for health professionals to be aware of these findings and ensure that 
priority is given to both seizure management and depression management in the 
treatment of individuals with epilepsy.
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Figure 1: General form of the structural equation model with “change in seizure
recency” latent variable.____________________________________________________
Depression
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Anxiety 1
Stress 1
Seizure 
recency 1
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Cey to Figure 1
Independent/Predictor /exogenous manifest (i.e. measured)variables
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Dependent/ Endogenous manifest (i.e. measured) variables- same variables at 
2 time points
Significance of Arrows
From independent -> dependent = path coefficients 
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Figure 2: Examining the effect of anxiety, stress and depression on “Change in
seizure recency” latent variable
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See Figure 1 and legend for Figure 1 for explanation of significance of shapes 
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T able 1: A com parison  o f the m ean and  s ta n d a rd  deviation  fo r non­
im puted  an d  im pu ted  scores fo r depression, anxiety , stress & seizure 
recency.______ ____________ ________________________________________
Variable Non imputed 
no.
Non imputed 
mean (sd)
Imputed no. Imputed mean 
(sd)
Time 1
Depression score
445 4.09 (3.32) 460 4.10(3.33)
Time 2
Depression score
418 4.38(3.57) 435 4.42 (3.59)
Time 1
Anxiety score
451 6.26(4.89) 460 6.27 (4.89)
Time 2 Anxiety 
score
429 6.45 (4.81) 435 6.51 (4.82)
Time 1 stress 
score
436 5.43 (3.56) 456 5.48 (3.54)
Time 2 stress 
score
418 5.67 (3.43) 438 5.67 (3.43)
Time 1 days 
since last seizure
402 1918 days 
(3034)
467 1971 days 
(3214)
Time 2 days 
since last seizure
340 2025 days 
(3133)
439 1990 days 
(2849)
T able 2: C o m p arin g  sam ple  charac teristics  in p resen t study  to 
ch arac te ris tics  from  the Jacoby  et.al (1996) com m unity  based study
Sample characteristic Present study (n=452) Jacoby et al, 1996 
(n=696)
Seizure status last year (n=452)
Seizure free last one year 49.6% 53%
At least one seizure per 
year but less than one 
seizure per month
25% 27%
One or more seizure per 
month
25.4 % 20%
Seizure type (not exclusive unless specified)
Tonic clonic seizures 50.7% 52%
Complex partial seizures 25.9%
Only tonic-clonic seizures 30.3% 34%
Demographic characteristics
Employed 41.3% 44.8%
Male 47% 49%
Mean age 51 years 46 years
Most commonly prescribed medication(n=444)
Sodium Valproate 29.7% N/A
Phenytoin 29.3% N/A
Carbamazepine 28.8% N/A
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Chapter 5
Investigating Individual Differences in 
Depression Scores Amongst People 
With Epilepsy: A Latent Growth Curve
Analysis.
Submitted Paper:
Thapar A, Kerr M, Harold G. Investigating Individual Differences in Depression 
Scores Amongst People With Epilepsy: A Latent Growth Curve Analysis
Abstract
Background: Depression is common amongst people with epilepsy and is an 
important determinant of quality of life. Depression scores are associated with seizure 
recency for people with epilepsy when they are examined as a group. However 
depression scores for individuals fluctuate over time and this has not been studied for 
people with epilepsy. The aims of this study were to examine the pattern and extent 
of individual differences in depression scores both at baseline and over time and 
examine the role that seizure recency plays in accounting for any such observed 
pattern of variation.
Methods: Questionnaire data on depression symptom scores (using the Hospital 
Anxiety & Depression (HAD) scale) and seizure recency from a three wave 
prospective, longitudinal study of adults with active epilepsy were obtained. Latent 
growth curve analysis (LGCA) was used for the analysis.
Results: Information was available from 325 individuals who completed all three 
waves of the study. Significant variation in baseline depression scores and changes in 
individuals’ depression scores over time were noted. Seizure recency significantly 
predicted individual heterogeneity in baseline depression scores ( p=0.247, p <0.05) 
as well as for changes in depression scores over time ( p =0.037, p<0.05) controlling 
for age across all analyses.
Conclusions: For people with epilepsy, seizure recency predicts differences in 
depression scores between individuals as well as changes in depression scores within 
individuals over time. Thus seizure management is important as it influences 
individual trajectories of depressive symptoms amongst adults with epilepsy.
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5.1 Background
Depression is an important problem for the general population (Kessler et.al., 2003). 
However for those individuals with chronic diseases depression has a particularly high 
impact (Stein et.al., 2006, Moussavi et.al., 2007). For the general population many 
different social, physical and psychological factors are known to affect depression 
(Kendler et.al., 2006) and considerable variation in depressive symptoms between 
individuals (inter-individual differences) has been reported (Judd et.al., 1998). 
However there has been much less research on differences in how depression 
symptoms for individuals change over time (intra-individual variation) and on how 
physical illness affects this variation.
People with epilepsy experience a high level of depressive symptoms (Strine et.al, 
2005, Ettinger et. al., 2004, Kanner, 2003) and considerable variation in depressive 
symptoms between individuals has also been noted (Kanner, 2003). What is not clear 
is how depressive symptoms for individuals with epilepsy change over time and how 
this varies for different individuals (intra-individual variation). Those with more 
recent or more frequent seizures have been found to have higher levels of depression 
scores (Jacoby et.al., 1996, Cramer et.al, 2003, Thapar et.al, 2005). However there has 
been little research on how seizures affect intra-individual change in depressive 
symptoms.
Latent growth curve analysis has started to be used to study individual change in 
psychiatric disorders (Hertzog & Nesselroade, 2003, Lenzenweger et.al., 2004). This 
approach is particularly useful in the situation where longitudinal studies show there is 
considerable stability in symptom scores over time, but that within this overall group
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stability there is considerable individual variation in symptom scores (Lenzenweger et.al., 
2004). This approach has however not yet been used to study variations in psychiatric 
disorder amongst people with epilepsy.
The aim of this paper is to examine, for adults with epilepsy, whether significant 
individual differences in depression scores and the individual trajectories that these 
scores follow are present, and if so, to test whether seizure recency is a significant 
predictor of this variation.
5.2 Method
Sample
A cohort of 564 adults with active epilepsy was recruited to participate in a 
longitudinal three-wave observational study. Individuals identified through general 
practices who had taken part in previous studies in Cardiff (Mensah at.al, 2006) and 
Manchester (Thapar et.al., 2002) were contacted and invited to participate in the 
present study. Ethical approval was obtained from the relevant local Research Ethics 
Committees (BroTaf and Salford & Trafford). A volunteer sample of people with 
epilepsy was also recruited through Epilepsy Action. Information was collected at 
three time points 5 months apart. A description of sample characteristics is provided 
in Table 1 (Page 109).
Measures
Participants completed a comprehensive package of well-known and validated 
measures of physical, social and psychological health (Thapar et.al, 2009) with the 
aim of collecting information which had been identified by the scientific literature as 
being associated with the severity and control of seizures for people with epilepsy.
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The following subsets of measures relevant to the present analysis were employed in 
the present study:
1. Anxiety and Depression. The Hospital Anxiety and Depression scale was used 
(Snaith & Zigmond, 1986). This is a widely used measure with good psychometric 
properties which has been successfully used in previous community based studies 
examining the quality of life of people with epilepsy (Jacoby et.al., 1996).
2. Seizure recency (Wagner et.al., 1995). Participants were asked how long it had 
been since they had their last seizure. This measure has been used in previous studies 
(Wagner et.al., 1995, Cramer et.al, 2004). The responses were converted to days since 
the last seizure and categorised. A 12 category variable was created with scores 
ranging from 12 (seizure in the last 24 hours) to 1 (last seizure was more than 15 years 
ago) with a midpoint score of 6 (last seizure was between 6 and 12 months ago) i.e. 
with the most recent seizures having the highest scores. Categorization was used for 
conceptual and clinical reasons as well as to overcome problems with model 
convergence.
Missing data
If there was partial non-completion of the item on seizure recency we used regression 
based imputation methods for seizure recency (Allison, 2001) using other information 
on seizure activity (using the missing data procedure in STATA). For depression 
scores if there was only one missing item, mean value imputation was used otherwise 
the response was coded as missing. A comparison of imputed and raw scores showed 
these were comparable (Thapar et.al., 2009).
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Statistical analysis
In our study we used latent variable growth curve analysis (LGCA) which was based 
on covariance structure analysis (Willett & Sayer, 1994) utilising the software 
package LISREL 8.5(Joreskog & Sorbom, 2001). When three or more waves of 
longitudinal data are available for analysis, latent growth curve (LGC) modelling is a 
more powerful technique for investigating relationships within data than simple 
regression (Lenzenweger et.al., 2004). LGC modelling allows the investigator to not 
only derive an estimate of differences in depression scores between individuals (inter­
individual differences), but also differences in how depression scores for individuals 
change over time (intra-individual variation). The principal advantage of a growth 
model is that information about mean change is incorporated into the modelling 
process, thus allowing for the inclusion of an estimate of the trajectory of intra­
individual growth. This can then be used to examine the pattern of individual 
variation in depression scores over time (see Figure 1, Page 109 and Figure 2, Page 
110) and the role of seizure recency and other theoretical predictors (e.g. age) in 
accounting for this pattern of variation (see Figure 3, Page 111). Further advantages 
of latent growth curve analysis have been summarised (Duncan & Duncan, 2004).
The method adopted for this analysis was to initially specify a theoretical model (as 
described in Willett and Sayer, 1994) to examine the extent and pattern of baseline 
inter-individual differences (“intercept”) and intra-individual variation (“slope”) in 
depression scores amongst adults with epilepsy. The model was then tested using the 
depression scores from the three time points (“unconditional model”) to examine 
whether there were significant inter-individual differences and intra-individual 
variation in depression scores and to assess how well the observed data fitted the 
model (using goodness of fit indices generated by the software). We then tested
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whether seizure recency and age were significant predictors of this pattern of 
individual variation in depression scores (a “conditional” model).
5.3 Results
564 individuals initially consented to participate. Of these individuals 341 were 
recruited from Cardiff, 108 from Manchester and 115 via Epilepsy Action. 468 
individuals responded to first wave questionnaires and 443 individuals responded to 
second wave questionnaires and 403 individuals responded to third wave 
questionnaires. The characteristics of the sample have been more completely 
described in a previous paper (Thapar et.al, 2009). Information from 325 individuals 
was available (depression score at all three time points and information on both 
predictors at Time 1).
On inspection of the data, considerable inter-individual differences and intra­
individual variation in depression scores were apparent. To illustrate this the 
depression scores for the first 254 individuals are plotted at the three time points 
(Figure 1, Page 109). As can be seen, considerable individual differences in the 
pattern and extent of variation of depression scores both across and over time exist.
Unconditional mode (examining the extent and pattern o f variation in depression 
scores)
This is illustrated in Figure 2 (Page 110). The results indicated significant individual 
differences in baseline depression scores (termed “intercept”: mean depression score 
4.19, variance 12.79; t-score 27.7, p <0.01) as well as individual differences in slope 
trajectories of depression scores over time (slope” mean change 0.16. variance 1.01, t 
score 2.36, p<0.05). There was good fit for the linear slope model (Root Main Square
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Residual (RMSEA) 0.009 (values less than 0.05 indicate a good fit), full information 
ML % 2 =3.11, p=0.375 (non-significant value indicates a “good” model as this 
indicates that the observed data (underlying variance-covariance matrix) does not 
significantly differ from that expected by the proposed theoretical model).
Conditional model (examining seizure recency and age as predictors o f variation in 
depression score)
The results are presented in Figure 3 (Page 111). Seizure recency significantly 
predicted both the individual variation in baseline depression scores (intercept P= 
0.247, p<0.05) as well as individual trajectories of depression scores over time (slope 
P= 0.037,p <0.05). These scores are path coefficients and can interpreted as similar to 
standardised partial regression coefficients. Age did not show any significant effect 
on either slope or intercept.
These results indicate that seizure recency is a significant predictor of not only of 
depression scores over time (intercept) but of individual differences in the trajectories 
of these scores (slope) over time. That is, where individuals vary in the trajectory of 
their individual depression scores over time, they vary as a result of activity in seizure 
recency assessed at an earlier point in time.
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5.4 Discussion
These results indicate that for adults with epilepsy followed up over a 10 month 
period there is significant variation between individuals in baseline depression scores 
as well as the individual trajectories that these scores follow over time. Seizure 
recency was a significant predictor of both the variation in inter-individual baseline 
depression scores and the intra-individual changes in depression scores over time. For 
this analysis we used depression scores rather than diagnoses of clinical depression. 
This is because there is considerable evidence that depression should be viewed as a 
continuum for research purposes (Judd et.al, 1998, Kessler et.al., 1997).
In this study we found that there is significant inter-individual variation in baseline 
depressive symptoms amongst people with epilepsy. This finding is broadly in line 
with the wide spectrum of depressive scores reported in other studies (Jacoby et.al, 
1996), and would be compatible with indirect evidence from the epilepsy literature 
which suggests that whilst there is an increased prevalence of depressive illness 
amongst people with epilepsy (Jacoby et.al., 1996) some individuals with well 
controlled epilepsy have similar levels of depression to the general population 
(Jacoby, 1992). Indeed in our study, variation in depression scores is greater than that 
reported in the general population. For example, normative data from a study based on 
a general population sample (figures from our study in brackets) showed a mean HAD 
depression score of 3.68 (4.19) with a variance of 9.4 (12.8) (Crawford et.al, 2001).
The significant variation in intra-individual changes in depression scores over time 
(slope trajectories) has not been previously investigated or reported. Other researchers 
have however noted there is considerable day to day variation in depressive symptoms
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in the general population (Judd et.al., 1998) and have also highlighted the impact of 
sub-threshold depressive symptoms (Judd et.al, 2000). There have been no equivalent 
studies for people with epilepsy although qualitative research suggests there is 
considerable variability in day to day psychological symptoms (Scambler, 1989).
Having established that there is significant individual variation in depression scores 
we next examined the effects of age and seizure recency in this individual variation in 
depression scores. We found that seizure recency but not age predicts inter-individual 
variation in depression scores over time. This finding is in line with other studies 
from the literature which have found that individuals who have more frequent seizures 
(Jacoby et.al, 1996, Thapar et.al., 2005, Mensah et.al, 2006) or those with more recent 
seizures (Cramer et.al, 2003,Thapar et.al., 2009) have higher depression scores. 
Conversely seizure free individuals have depression scores that approximate the 
depression scores from the general population (Jacoby 1992, Jacoby et.al, 1996). 
However previous studies have either been cross-sectional (Jacoby et.al, 1996,
Cramer et.al, 2003, Mensah et.al, 2006) or if longitudinal (Thapar et.al, 2005, Thapar 
et.al, 2009) were “group level” analyses (that is, variation around group level scores 
for one variable is assessed relative to concomitant variation for a second, or further 
set of variables) and these include techniques such as correlation, regression, and 
some SEM techniques. These techniques aim to minimise the variance by the 
prediction rather than explain the pattern and predictors of the individual variation 
observed. Latent growth curve analysis facilitates such examination and is the 
approach taken in the present study. Moreover, it has been highlighted that this is an 
important distinction as group level changes can be very different from individual 
changes (Herzog & Nesselroade, 2003).
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We also found that seizure recency predicted some of the individual changes in 
depression scores. This has not been examined in the past for people with epilepsy 
although qualitative research suggests that how long ago a seizure occurred may have 
affected current psychological functioning for some patients (Schneider and Conrad 
reported by Scambler, 1989). For individuals who have just had a myocardial 
infarction, emerging research suggests that there is considerable intra-individual 
variation in anxiety and depression scores and that severity of illness can explain part 
of the intra-individual variation for the sub-group of individuals who also have 
diabetes (Murphy et.al, 2008). Future analytic aims from the current study would be 
to examine specific subgroups of individuals (for example by gender) to see if these 
played a role in moderating the affect of seizure recency.
Seizure recency rather than seizure frequency was used as the predictor for this 
analysis. This distinction was made a priori as a previous analysis on two wave data 
from this dataset found similar results for seizure recency and seizure frequency as 
predictors of depression scores (Thapar et.al., 2009). Moreover there have been 
several studies which have found both seizure recency and seizure frequency have 
similar effects on quality of life (Mrabet et.al, 2004 ) and previous studies have used 
seizure recency in preference to seizure frequency (Cramer et.al, 2004)).
The principles and strengths of latent growth curve analysis in studying individual 
change have been well described (Willet & Sayer, 1994, Muthen & Curran, 1997, 
Wickrama et.al, 2002, Llabre et.al, 2004, Lenzenweger et.al, 2004). The present study 
however represents the first application of this approach to the understanding of
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individual differences in depression scores among adults with epilepsy. This study 
adds another powerful argument for the relationship between seizures and depression 
scores and highlights the importance of reducing the occurrence of seizures to 
improve depression symptoms amongst adults with epilepsy.
The limitations of the study need to be borne in mind. As with almost all longitudinal 
studies there was sample attrition during the study. There was an increase in 
depression scores over the course of this study even though the study was an 
observational study which raises the possibility of selective dropout. However as can 
be seen from an inspection of the individual growth parameters (curves), there was 
wide variation in how individual scores changed over time with some scores 
increasing and some scores decreasing and moreover more than 80% of participants 
provided information on at least two data points.
Conclusion
The results of our study indicate that individuals with epilepsy vary from each other in 
their depression scores and in how their individual depression scores change over 
time. Some of this variation can be predicted by how long ago the last seizure was. 
This has important implications for the delivery of treatment and for understanding 
the source of depression amongst people with epilepsy
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Figure 1: Examining Individual trajectories of depression scores for the first 254
participants
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Table 1 Comparing characteristics of responders for the three waves of data
Characteristic Time 1 Time 2 Time 3
Mean age: Years (SD) 51.2(17.3) 51.9(17.1) 52.4(16.4)
(n=447) (n=421) (n=386)
Gender: % male 47.2 47.1 46.3
(n=460) (n=435) (n=400)
On income support: 14.8 15.0 15.0
<%) (n=433) (n=420) (n=367)
One or more seizures a 25.4 26.7 23.8
month (%) (n=452) (n=436) (n=390)
Individual tra jec to rie s  of d ep re ss io n  sco re  for initial 254 partic ipan ts
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Figure 2: Unconditional latent variable growth curve model (n=325)
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Figure 3: Conditional latent variable growth curve model showing the 
relationships between age and seizure recency on depression score slope and 
intercept
seizure
Variance
1.01
Variance
12.8
Intercept
Mean
4.184
Depression 
score Time 1
Depression 
score Time 2
Depression 
score Time 3
R M S E A  = 0 . 0 0 8  
M L x 2 =  3 . 1 1 0  ( p = 0 . 3 7 5 )
* p<0.05
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Chapter 6:
Discussion
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6.1 Main findings
In this programme of study the overall aims were to disentangle the relationships 
between psychological factors and seizures. The specific aims were:
1) To examine the nature of the relationship between depression symptom scores and 
seizure frequency amongst people with epilepsy by specifying and testing different 
theoretical explanatory models of this relationship.
2) To examine how depression, anxiety and stress act separately and in combination 
to influence seizures.
3) To examine the pattern and extent of individual variation in depression symptom 
scores amongst people with epilepsy over time.
4) Investigate whether seizure recency predicts individual variation in depressive 
symptoms.
5) Learn appropriate multivariate statistical analytic techniques to be able to examine 
these relationships.
A summary of the findings with respect to the main aims will first be presented.
1) What is the nature o f  the relationship between depression symptom scores and 
seizure frequency?
A bidirectional relationship was found between depression scores and seizure 
frequency for adults with active epilepsy. Depression scores significantly predicted 
both future and concurrent seizure frequency and seizure frequency significantly 
predicted both future and concurrent depression scores. This was controlling for the 
association between seizure frequency and depressive scores at baseline and all 
relationships were analysed simultaneously.
2) How depression, anxiety and stress act separately and in combination to influence 
seizures.
When analysed separately, anxiety scores, perceived stress and depression scores 
predicted future seizure recency. Depression however mediated the relationship 
between anxiety and stress with seizure recency, that is, the effects of anxiety and 
stress on seizure recency could be explained by their concurrent relationship with 
depression scores. There was no evidence of a moderator relationship, that is, none 
of these psychological factors significantly influenced the relationship between 
another psychological factor and seizure recency. Exactly the same pattern of results 
was obtained when seizure frequency was considered as an outcome variable.
3) To examine the pattern and extent o f individual variation in depression symptom 
scores amongst people with epilepsy over time.
Significant differences in baseline depression scores between individuals (inter­
individual differences) were found. There was also significant variation in how 
depression scores for different individuals changed over time (intra-individual 
variation). Although the inter-individual differences in depression scores amongst 
people with epilepsy have been appreciated for some time, intra-individual variation 
in depression scores has not previously been documented for adults with epilepsy.
4) Investigate whether seizure recency predicts individual variation in depressive 
symptoms.
Seizure recency was found to be a significant predictor of both sources of individual 
variation (inter-individual differences and intra-individual variation) in depression 
scores amongst people with epilepsy controlling for age in all analyses.
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5) Learn appropriate multivariate statistical analytic techniques to be able to examine 
these relationships.
In this project, path analysis, latent variable modelling and latent growth curve 
analysis were used for the analysis of longitudinal data after appropriate training. 
These techniques are all part of the structural equation modelling family of 
techniques. The analytic methods were tailored to the data, information available and 
objectives of the analyses. The value of a prospective longitudinal design was 
realised and yielded useful information. Structural equation modelling techniques 
were useful tools for the analyses as they were versatile and flexible and the approach 
of specifying theoretical models and testing against empirical data was attractive. Path 
analysis using cross lagged and reciprocal models offered a relatively simple 
technique which allowed an examination of direction of effects between seizures and 
depression. Random effects latent variable modelling was found to be suitable to test 
models for two wave data when outcome variables had relatively high stability and 
where the aim was to explore inter-relationships and to test for moderation and 
mediation. Latent growth curve analysis was a powerful technique for examining 
individual variation in symptom scores (both inter-individual differences and intra­
individual variation) and examining the effects of predictors on this variation.
6.2. Implications of this work for knowledge about relationships between 
psychological factors and physical illness
6.2.1. Direction o f associations between depression and seizures 
A bi-directional relationship between seizure frequency and depression scores was 
found. This advances current knowledge on the links between seizures and depression
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as previous studies have shown an association, but, being cross-sectional, do not allow 
any definitive conclusions to be reached regarding causation (Rutter et.al., 2001, 
Susser et.al, 2006). Over the last few years there has been more interest in the 
relationship between seizure activity and depression and longitudinal study designs, 
often in the context of an intervention, have been used. However uncertainty has 
remained about the nature of the association because of confounders or because of 
concerns about generalisability of findings. Devinsky et.al (2005) found that after 
epilepsy surgery, depression scores in seizure free patients were lower than in those 
patients who continued to have seizures. However in a review of this study,
Schachter (2008) suggest that alleviation of depression and anxiety in this study could 
also arise through removal of affected limbic areas, less fear of seizures, improved 
sense of control and stopping anticonvulsant medication. This sample consists of 
patients selected for epilepsy surgery, so results may not be representative. In another 
study, the MeSS study, Jacoby et al (2007) reported at two year follow up that there 
were lower rates of depression amongst those patients who became seizure free 
compared to those patients who continued to have seizures. However, in this study 
those patients who were on anticonvulsants were also more likely to be depressed. 
Given the pattern of adverse effects from anticonvulsants (Ketter et.al., 1999), the 
lower rates of depression in the seizure free group could relate either to less seizures 
or less use of anticonvulsants and indeed, once the models in the MESS study were 
adjusted for anticonvulsant status, depression effects for seizure status became 
insignificant. Marson et.al. (2007) examined the relative effectiveness of different 
anticonvulsants for the treatment of partial seizures and found that for those patients 
who achieved a remission of seizures, depression scores were lower. It is not clear 
however whether this finding would apply to those with generalised seizures.
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6.2.2. The role o f stress and in worsening seizure control.
Stress has been highlighted as a major risk factor for worsening of seizures by patient 
surveys. Psychological factors are known to be highly correlated (Susser et.al. 2006) 
and inter-relationships between seizure activity and stress and anxiety have been 
proposed (Frucht et.al, 2000, Beyenburg et.al, 2005). Plausible mechanisms 
accounting for a link have also been suggested. The current study has found that both 
anxiety and stress exert their effects on seizure activity through depression symptoms. 
This clarifies the precise interrelationships between anxiety, stress and seizures (Haut 
et.al, 2007) and is in line with other studies on the general population which have 
found the importance of negative affectivity on the relationship between stress and 
health (Watson & Pennebaker, 1989). However this topic has not been much studied 
for chronic illnesses. Anxiety and stress were also not found to act as moderators for 
the relationship of depression scores with seizure activity.
6.2.3. The course o f depression amongst individuals with epilepsy 
Differences in depression scores between individuals with epilepsy have been long 
appreciated. The current study adds to this finding by demonstrating that there are 
significant fluctuations in depression scores over time for individuals with epilepsy. 
This is in line with findings on depression scores in the general population (Judd et. 
al., 1998). This is important to demonstrate as it was entirely plausible that chronic 
illness may be exerting effects which would have altered the pattern of fluctuation of 
depression scores particularly as high stability values were obtained for depression 
scores over time.
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6.2.4. The role o f seizures on individual changes to depression scores.
The association of seizure activity and depression scores have been long appreciated. 
The current study builds on these observations by demonstrating that seizure recency 
is a significant predictor of individual fluctuation in depression scores. This finding 
considerably strengthens the argument that seizures do have an effect on depression 
scores.
6.3. Clinical implications
6.3.1. Depression amongst people with epilepsy
Depression rates are elevated amongst people with epilepsy. It has been argued that 
depressive symptoms may be viewed as a natural consequence of living with an 
unpredictable chronic illness. It has also been noted that managing depression 
amongst people with epilepsy can be viewed as difficult (all antidepressants generate 
automatic warnings on prescribing systems that they may exacerbate epilepsy) and 
many GPs express reservations about their knowledge and skills in managing people 
with epilepsy (Thapar et.al, 1998, Thapar et.al, 2002). This can lead to the situation, 
which has been found, of suboptimal treatment of depression amongst people with 
epilepsy (Kanner et.al., 2000). The findings of the current study highlight the 
importance of treating depression amongst people with epilepsy. However for 
implementation of improved depression management in the clinical setting a 
systematic strategy is likely to be necessary. Some general practitioners are not 
confident about their knowledge of epilepsy (Thapar et.al., 1998) and as it would 
seem likely this will extend to psychological issues related to epilepsy (although there
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is a paucity of research which has examined this issue). Moreover it has also been 
argued that many neurologists either are not aware of the importance of depression or 
do not view depression management as a required part of epilepsy management 
(Kanner, 2005c). An important first stage would therefore be to increase awareness 
amongst clinical staff of the importance and implications of depression amongst 
people with epilepsy and the relevance of depression management to good seizure 
control. There should then be improved screening for depression amongst people 
with epilepsy (for example by using either a generic depression screening 
questionnaires such as the Hospital Anxiety and Depression Scale or the newer more 
epilepsy specific Neurological Disorders Depression Inventory for Epilepsy (Gillam 
et. al, 2006 )). Finally if depression is identified it would be important to implement 
effective treatment of depression (such as by using antidepressants or cognitive 
behaviour therapy). The safety of newer antidepressants (such as the SSRIs) for the 
treatment of depression for individuals with epilepsy has been established (Kanner 
et.al., 2000) and guidelines for antidepressant treatment of epilepsy are available 
(Schmitz, 2002). Finally, policy initiatives such as including depression screening for 
people with epilepsy in the General Practice Quality and Outcomes framework may 
be very valuable for ensuring depression management for people with epilepsy in 
primary care is targeted as a priority area.
6.3.2 Managing Stress and anxiety amongst people with epilepsy
Stress is viewed as the commonest precipitant of seizures by people with epilepsy
(Nakken et.al, 2005). However stress is a common experience (Cohen et.al, 1997).
The current study showed that depression mediates the relationship between stress and
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anxiety and seizures. These findings suggest that if an individual with epilepsy is 
found to be stressed (or anxious), depression should be screened for and treated to 
avoid effects on seizures. The clinical implications of this are considerable. The 
results suggest that detecting and treating depression should be prioritised above stress 
or anxiety management in epilepsy care. There are differences in the management of 
anxiety and depression (NICE, 2004a, NICE, 2004b). This distinction is also 
important give the limitations on time and resources both in primary and secondary 
care. Stress may however play however other roles in epilepsy, such as acute stress 
acting as a trigger for individual seizures or as an antecedent factor for depression and 
seizures. These could be examined in future work using a different study design.
6.3.3. Seizure management
There have been several studies which have highlighted that depression amongst 
people with epilepsy is the main factor involved in determining the quality of life of 
people with epilepsy (Loring et.al, 2004, Tracy et.al, 2007), which may have had the 
effect of indirectly marginalising the importance of good seizure management. The 
current study has provided strong evidence for the importance of also obtaining 
optimal seizure control for people with epilepsy.
6.3.4. Individual variation in depression scores
It was found in the current project that although there were relatively small changes in 
mean depression scores over the course of the study, considerable differences in 
individual depression score trajectories were evident when plotted graphically and this 
variation was significant when analysed statistically. This finding would suggest that 
individually tailored approaches to depression management based on following up
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patients may be important (some clinical software programmes have the ability to 
graphically display scores from psychiatric rating scales). However which pattern of 
fluctuation is most likely to respond to interventions is not clear at the present time.
6.3.5. Statistical versus clinical significance
One issue that is often raised is the issue of statistical versus clinical significance. 
Many of the results presented show relationships that are statistically significant but 
with small coefficients, so the issue of clinical significance arises. As has been noted 
earlier there is no consensus at the present time as to what represents a clinically 
significant change in depression score and seizure frequency. However some guides 
as to significance can be proposed. One guide would be by looking at the proportion 
of variance in the endogenous variable explained by the model proposed (R ). In the 
first study the R 2 for depression at Time 2 was 0.54 and for seizures at Time 2 was 
0.77. This would mean that 54% of the variance in the depression scores at Time 2 
could be explained and 77% of the variance in the seizure frequency scores at Time 2 
could be explained and most of the variation is explained by Time 1 scores of the 
same variable. The R 2 for change in seizure frequency or recency may in contrast 
seem very low. However as there are no prior seizure frequency or recency scores, 
this result suggests that 12% of the inter-individual variation in seizure recency is due 
to psychological factors which is similar to that found in the cross lagged model. 
Psychological factors were found to explain 9% of the variance in the quality of life of 
people with epilepsy in another study (Suurmeijer et.al.,2001). Moreover, it has been 
argued that simply using the percentage of explained variance can underestimate the 
effect of systematic factors on processes (Abelson, 1985)
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6.4 Implications for analyses
The programme of study utilised different analytic methods for different study aims. 
This approach also yielded some insights into how further work should be carried out.
6.4.1.Having longitudinal data is much more useful than cross sectional data 
Having longitudinal data offers the possibility that one can make causal inferences 
about the variables in question, whereas cross sectional data do not.
6.4.2. Having more than one measure o f a construct is useful
Latent variables can be defined on the basis of two (preferably three) measured 
variables that tap the same construct. In the second study, a latent variable was 
defined based on seizure recency scores from two time points. This allows the “error 
variance” to be partialled out of the latent variable which improves the predictive 
power of the variable (Loehlin, 1998).
6.4.3. Having three or more waves o f data is much more useful than having two 
wave data
There are several advantages to having three or more waves of data. Having 
information at three or more time points enable non-linear patterns of change over 
time of variable scores to be identified. Two wave data analysis assumes a linear 
pattern in the change of scores of variables. Many processes result in non-linear 
changes (Hayes et.al., 2007). Moreover having three time point data allows techniques 
like latent growth curve analysis to be used for analysis which allows information on 
individual fluctuations in symptom scores to be used for prediction purposes which 
provides more powerful evidence on the importance of predictors than group based
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approaches. Multiple regression and path analysis are sometimes termed group level 
approaches as the aim is to minimise individual differences whereas latent growth 
curve analysis utilises the individual variation in scores and allows factors to be 
specified in the model which explain the causes of this individual variation 
(sometimes also termed variance based approaches).
6.4.4. Structural equation modelling approaches are under-used in clinical research 
Structural equation modelling approaches are rarely used in clinical research which 
emphasises simpler regression based approaches. One major advantage of structural 
equation modelling for clinical research is that models (scenarios) are hypothesised on 
the basis of existing empirical evidence and can be tested against observed data. SEM 
has been criticised as claims have been made about causality on the basis of a good 
model fit whereas other models may have fit the (correlational) data equally well. 
However if the fact that there is often more than one plausible explanation for any 
situation arising is appreciated and competing models are specified, this apparent 
weakness can become a strength as these models can then be compared on the basis of 
goodness of fit indices.
6.4.5. Dimensional measures offer advantages in research settings
A dimensional approach to depression (as well as anxiety and stress) was adopted 
throughout this programme of work. Using dimensional measures offers advantages 
for data analysis (Tabachnick & Fidell, 2001) and is also in line with 
recommendations that depression is best treated dimensionally for research purposes 
(Andrews et.al., 2008) and that that there is no clear cut off in terms of impact of
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depression symptom scores on outcomes (Kessler et.al., 1997). This issue has also 
been discussed in the subsections of the depression, anxiety and stress sections of the 
Background.
6. 5. Strengths and limitations
6.5.1. Strengths
6.5.1.1 Sample Both studies used data from community based samples of adults with 
active epilepsy. A relatively large number of adults with epilepsy agreed to 
participate and although not all individuals completed all three waves of 
questionnaires and not all individuals who completed questionnaires completed all the 
different sections, more than 80% of individuals who had consented to participate and 
had not died or withdrawn at the first questionnaire stage completed at least two 
questionnaires. In addition, the disease characteristics (such as severity and seizure 
type) and socio-demographic characteristics (age, gender, employment) of the 
samples recruited were comparable to the sample characteristics from other large 
community based studies of adults with epilepsy from different geographical areas. 
Sample heterogeneity was however noted for the second study sample. This probably 
arose because a variety of recruitment strategies were used. Higher seizure frequency 
and different seizure subtype profile in the sample recruited from the epilepsy charity 
was found. Separate analyses were carried out for each of the two subgroups. 
Interestingly, despite these considerable differences in the sample, identical results 
were found. This replication of results indicated the findings are more robust (Susser 
et.al., 2006).
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6.5.1.2. Measures: The measures used to measure anxiety and depression (the HAD 
scale), stress (the Perceived stress scale) and seizure frequency are all well 
established, psychometrically tested measures which have been widely used in 
community based studies. Although psychiatric interviews are the gold standard for 
diagnosis it has been argued that questionnaire ratings show high concordance with 
interview findings and are more pragmatic for longitudinal studies on large 
community based samples (Kroenke et.al, 2001).
6.5.2. Limitations
6.5.2.1. Sample Not all individuals who commenced the study completed the study 
(19% of individuals who completed the first questionnaire did not complete the 
second questionnaire). Self-report measures were used to derive information and this 
could have influenced findings. It has been argued that information from other 
informants should also be used to increase the validity of information. However, using 
other informants in a large-scale community-based study was not feasible and at 
present little is known on the validity of information on seizure frequency and 
depression provided by other informants.
6.5.2.2. Measures An ordinal measure of seizure frequency was used. Polychoric 
correlation matrices were derived and these facilitate analysis of both continuous 
(depression scores) and non-continuous (seizure frequency) measures while adhering 
to the important assumption of multivariate normality. It is possible however that 
using an ordinal measure for seizure frequency and a continuous measure of 
depression scores could result in less power to detect a difference in terms of
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influence of the ordinal variable (Pickles, personal communication), the fact that 
bidirectional effects were demonstrated would suggest this would not have influenced 
the overall conclusion.
6.5.2.3. Measurement time frames
The measures do not reflect information from exactly the same period in time (seizure 
frequency is measured over the past year, seizure recency is the time since the last 
seizure, depression scores and anxiety scores refer to symptoms in the past week and 
perceived stress scores ask about perceptions over the last month). However there are 
high stability levels for all these variables. Moreover the overall effect is likely to 
underestimate coefficients rather than overestimate them.
6.5.2.4. Seizure type.
Previous research has suggested that individuals with partial epilepsy are more likely 
to be depressed but findings have been mixed (Indaco et.al, 1992). In the first dataset, 
which used recorded information on seizure type, it was found that the sample size for 
individual seizure types was not large enough to test structural equation models for 
each seizure type but in a regression analysis, using seizure types as independent 
variables, only a history of tonic-clonic seizures significantly predicted depression 
scores. We also examined the association between seizure type and depression using 
data from the second dataset. Individuals who self-reported a history of complex 
partial seizures were more likely to be depressed. It has been noted that complex 
partial seizures are prone to being under-recognised and it is possible that self-reports 
may provide a more accurate estimate of whether or not an individual had complex
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partial seizures than recorded information which may only record the initial seizure 
type. This will be important to further investigate in future research.
6.6. Future work
6.6.1. Confirm the bi-directional relationship between depression and seizure 
frequency and elucidate the reason for this association
A bi-directional relationship between depression scores and seizure frequency was 
demonstrated but this is generally felt to be inadequate in providing robust evidence 
of causality (Rutter et.al, 2001). Moreover the mechanism by which this association 
arises needs to be elucidated; for example is this behavioural and/or neurobiological? 
To test for causality it is recommended that either a natural experiment or a 
randomised controlled trial design should be adopted (Rutter et.al, 2001). However 
before these can be set up, an appreciation of threats to the usefulness of findings 
from controlled trials and natural experiments is needed. For controlled trials threats 
to usefulness include sample selection, generalisibility of findings, inappropriate 
outcomes selected, inadequate length of follow up and sample size issues (either 
inadequate power to detect differences or too large to ensure standardised 
interventions/ contexts). Some of these reasons may be relevant in interpreting the 
results of recent well-designed and resourced trials on treating depression in 
individuals with chronic illnesses which have generally not been able to demonstrate 
significant benefit in terms of improved physical disease outcomes (Glassman et.al, 
2002, van Melle et.al, 2007). Natural experiments are a promising alternative but are 
dependent on appropriate circumstances arising.
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6.6.2. Examine whether there is a common antecedent factor which would explain the 
pattern o f results between depression and seizures
For this there is a need to identify the processes by which depression and seizures 
have evolved. One possible strategy would be to design a prospective longitudinal 
study of individuals before they develop either depression or seizures and follow them 
up until they develop these outcomes. This could be either based on a general 
population sample or a high-risk sample (for example if there is a family history of 
epilepsy). There are existing cohort studies (e.g. the ALSPAC study) which are 
following up a cohort of children from birth. Provided appropriate data have been 
collected, the results from this study could be used to study this process.
6.6.3. Psychological variables and their effects on seizure occurrence
Given that anxiety and stress predict changes to seizure frequency and recency and 
that this mediated by depression, it would be important to examine whether the same 
pattern of inter-relationships apply when the effects of these psychological variables 
on the occurrence of individual seizures is considered. This would involve using 
diary designs and appropriate analytic techniques such as survival curve analysis.
The relationship between fear of seizures, psychological factors and seizure outcomes 
also seems to be a promising area of research.
6.6.4. Examine relationships between psychological variables and seizure measures 
for complex partial seizures.
Those individuals who suffered from complex partial seizures were found to have 
more frequent seizures and significantly higher depression scores than individuals 
who had other seizure types in the second sample (Page 83). It has been suggested
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that the organic basis of the relationship between complex partial seizures and 
depression may be different than that for other forms of epilepsy (Kanner, 2005(b)).
It would be important to examine whether the models specified in the current study 
also apply to those individuals with complex partial seizures.
6.6.5. Depression symptoms
It was found there was significant individual variation in depression scores over time 
amongst the sample of individuals with epilepsy and that some of this variation could 
be explained by seizure recency. However depression scores are an aggregation of 
scores derived from several different symptoms. It was highlighted by one of the 
anonymous reviewers for one of the papers that it would be important to examine the 
effects of epilepsy on repeated measures of minor psychiatric symptoms. This is 
particularly important as some of the psychiatric symptoms included in common 
generic depression scales can also arise as iatrogenic side effects of anti-convulsant 
drugs and compliance can be variable. It has also been highlighted that some 
symptoms tend to have low variability over time and other show a more fluctuant 
course (Quinn & Martin, 1999).
6.6.6. Effect o f gender on these relationships
Epilepsy is an unusual chronic illness in that there is an equal prevalence of 
depression amongst males and females (Mensah et.al, 2006). It is possible the 
processes which influence depression are different in males and females with epilepsy 
than those in the general population. Thus it will be important in the future to 
separately examine depression amongst men and women with epilepsy and examine 
the role of predictors such as seizures.
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In summary, this work has shown the links between depression and seizures and 
provided empirical evidence to underpin the importance of effective seizure 
management and depression management for people with epilepsy and highlighted the 
future work that needs to be done.
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Appendix 1
Sequence o f analysis (Path model)
Cross lagged panel analysis).
An example of a cross lagged panel analysis model using path analysis is given below 
We are looking a two time points (Time 1 and Time 2) and two variables (seizure 
frequency and depression).
Depression 
scores at 
Time 1
Seizure 
frequency 
at time 1
Seizure 
frequency 
at Time 2
Depression 
at Time 2
To illustrate how this was arrived at this will be broken down into steps.
1) We know from the literature that depression symptoms are quite persistent 
although severity does fluctuate (Judd et.al.1999). Therefore a major determinant of 
depression scores at Time 2 will be depression scores at Time 1. Using the 
convention for path analysis, boxes represent the fact that the variables are measured 
and the arrows represent paths (relationships) that are equivalent to standardised 
regression coefficients this can be represented by (see overleaf):.
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Depression Depression
scores at ----------------------------------- ---- ► scores at
Time 1 Time 2
2) It is also clear that seizure frequency is also quite stable for many individuals 
(Thapar et. al, 2005). Thus again a major determinant of Seizures at Time 2 will be 
seizures at Time 1. This can be represented by:
Seizure 
frequency 
at time 1
►
Seizure 
frequency 
at Time 2
3) Several research studies have highlighted that there is an association of seizure 
frequency with concurrent depressive symptoms. The existing diagrams can be 
modified to now be represented as below (the curved arrows represent association 
with no implicit statement regarding causation.)
Seizure Seizure
frequency ----------------------------------------^ frequency
at time 1 at Time 2
Depression Depression
scores at at Time 2
Time 1 ------------------------------------------ ►
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4) Seizure frequency has been found to be a predictor for depression scores 
(Thapar,2001). When this pathway is added to the previous model the figure below is 
arrived at:
Seizure 
frequency 
at time 1
►
Seizure 
frequency 
at Time 2
Depression 
scores at 
Time 1
Depression 
at Time 2
5) Finally what we are particularly interested in is whether depression symptoms at 
Time 1 predict seizure frequency at Time 2, taking all these other relationships into 
consideration . This can be represented as
Depression 
scores at 
Time 1
Seizure 
frequency 
at time 1
Seizure 
frequency 
at Time 2
Depression 
at Time 2
This is the cross-lagged panel analysis detailed at the start of this section.
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A ppendix  2
Structural equation modelling: Underlying model and specifications 
A diagrammatic explanation of a type of model used in SEM is provided in figure 2.2
The underlying matrix for LISREL can be defined using the figure below:
Phi
Psi Structural part of model
Beta
Ksi
endogenous
endogenousexogenous
Psi 4
V  42
Phi
,» .3 l
Zeta j Zeta 2
Beta
Gam ma 
f  ( y )  22 Beta
P 42Eta Eta
exogenous
Psi endogenous endogenous
22
Lambda 32
Lambda 32
Lambda Lambda 2 2Lambda 12
Delta EpsilonEpsilon 1 EpsilontDelta D elta
Measurement part of model
x= measured exogenous variables, 4 (ksi)== latent exogenous variables, y-measured endogenous variables, T ]  (eta)- latent 
exogenous variable, X (lambda)= path from measured variables to measured variables, y  (gamma) =path from exogenous to 
endogenous variables, P (beta) path from one endogenous variable to another, <p (phi) correlations between exogenous variables, 
v)/ (psi) = correlations between endogenous variables, 5 (delta) errors associated with measured exogenous variables and e 
(epsilon) errors associated with measured endogenous variables, £(zeta) error associated with latent endogenous variables.
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Once the theoretical model has been defined (e.g. Figure 2.2) we can use the previous 
diagram to specify the model for the analysis. For the cross lagged model we 
highlighted earlier this would be specified as in the Figure on the next page 
(underlined text explains specification):
C r o ss  l a g g e d  a p p r a i s a l s  t e s t  Line  1: T i t l e  for  records
DA NI=4 N0=905 MA=CM
LABELS 
2 3 4 5
CM
1 . 0 0 0  0 . 3 0 6  1 . 0 0 0  0 . 8 7 7  0 . 2 9 9  1 . 0 0 0  
0 . 2 8 7  0 . 7 3 0  0 . 3 3 3  1 . 0 0 0
ME
0 . 0 0 0  5 . 2 1 5  0 . 0 0 0  5 .2 91  
SD
1 . 0 0 0  3 . 7 7 9  1 . 0 0 0  3 . 9 8 9
S u b j e c t s . Matrix tvDe (CM=correlation
matri x)
Line 3-4:  
data f i l e
Which o f  the v a r i a b l e s  in the 
s e l e c t e d
Line 5 - 6 : c o r r e l a t i o n s  between var iab les
Line 6-7: means o f  the v ar ia b l e s
Line 8 -9 : standard d e v i a t io n  o f  the
v a r i a b l e s
SE
4 5 2 3 /  Line 10-11: sequence o f  a n a l y s i s
(endogenous-* exogenous)
M0 NX=2 NK=2 TD=FU,FI LX=SY,FI PH=SY,FI NY=2 NE=2 TE=FU,FI LY=SY,FI PS=SY,FI
Line 12: number o f  measured exogenous v a r i a b l e s ( x ) . number o f  l a t e n t  exogenous  
va r i ab l es  (k s i ) .  propert i e s  of  matrices appl i ed  to exogenous ma tr ices  (Lambda X 
(measured-*latent)  and error ( theta d e l t a ) :  SY=svstem, FU= f u l l .  FI= f i x e d ) ,  number of  
measured endogenous va r i ab l es ,  number of  l a t e n t  endogenous v a r i a b l e s ,  pro pe rt i e s  of  
matrices  appl i ed to  endogenous var iab les  (Lambda Y(measured -> l a t e n t )  and error  
( theta e p s i l o n ) )
GA=FU, FI BE=FU, FI
Line 13: Propert i e s  of  Gamma and beta matr ices  
ST 1 LX 1 1 LX 2 2
Line 14: S tar t ing  va lu es  for exogenous v a r i a b l e s  and sequence o f  a n a l y s i s
FR PH 1 1 PH 2 2 PH 2 1
Line 15: which exogenous paths to  f ree )
ST 1 LY 1 1 LY 2 2
Line 16: S tar t ing  va lues  for  endogenous v a r i a b l e s  and sequence o f  a n a l y s i s
FR PS 1 1 PS 2 2 PS 2 1
Line 17 :which endogenous paths to  f re e
FR GA 1 1 GA 2 2 GA 1 2 GA 2 1
Line 18: sequence o f  a n a ly s i s  o f  gamma matr ices  
LK
FIT1 M00D1
Line 19: la b e l s  to be used for exogenous v a r i a b l e s  
LE
FIT2 M00D2
Line 20: la b e l s  to be used for  endogenous v a r i a b le s  
PATH DIAGRAM 
0U TV SC EF AD=0FF
Line 20-21: Output opt ion s  _______________________________________________________________
In this model as no latent variables are being specified on Line 12 the number of x 
variables = number of ksi variables and y variables = and number of eta variables and
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on Line 14 and 16 the specification indicates the onerone mapping of the measured to 
the latent variable for both the exogenous and the endogenous variables.
Seizure 
frequency 
at time 1
Depression 
scores at 
Time 1
Seizure 
frequency 
at Time 2
Depression 
at Time 2
Underlying algebra
The basic equation for the structural part of the model is :
Pn (effects of endogenous variables on themselves)
(effects of exogenous variables on endogenous variables)
£ (error in endogenous variable)
r  (gamma) and p (beta) are path coefficients and the other terms are latent variables
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Latent variable modelling
This would be specified as :
Ajay Model anxiety stress depression fits full sample
DA NI=5 N0=386 MA=CM 
LA
ANX1 STRESS1 DEP1 FITS1 FITS2 
KM
1.00 0.632 1.00 0.656 .526 1.00 .259 .237 .293 1.00 .263 .232 .291
.839 1.00 
ME
2.523 5.377 1.123 0.000 0.000 
SD
0.934 3.567 0.781 1.000 1.000
MO NY=5 NE=4 LY=SY,FI TE=SY,FI PS=SY,FI BE=SY,FI 
LE
anxiety stress depress fits 
ST 1 ly 1 1 ly 2 2 ly 3 3 ly 4 4
FR LY 5 4
FR TE 4 4 TE 5 5
FR PS 1 1 PS 2 2 PS 3 3 PS 4 4 PS 2 1 PS 3 2 PS 3 1
FR BE 4 1 BE 4 2 BE 4 3
Path Diagram
OU TV SC SV EF AD=0FF
Notes.
1)This model is specified as an endogenous variable model so there are no terms 
referring to the exogenous side of the model (i.e. no x terms, k s i , phi or theta delta 
matrices specified). This is not a problem as long as the pattern of relationships in the 
diagram is maintained. This is indeed a strength of SEM, that the endogenous variable 
in one analysis can become the exogenous variable in another analysis.
2) The fact that a latent variable is included can be noted by NY>NE, a lambda Y 
matrix being included and from the specifications on the PS and BE matrix and the 
inclusion and freeing of (i.e. asking for estimations o f) the TE matrices (error)
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Latent G row th C urve m odelling
The specification for this model using LISREL is:
DA Ng=1 NI=6 No=325
RA FI=E:\newbasicgrowth201006predictors.pr2 RA: Case by case raw data
LA
'depV 'dep2' 'dep3' 'fi t s1' 'severity' 'age'
Se
1 2  3 4 6/
Model ny=3 Ty=ze Ne=2 Te=sy,fi Nx=2 Tx=Fr Nk=2 Td=ze ph=sy,fr al=fr
be=ze Ga=Fu,Fi ps=sy,fr AL matrix:  in te rc ep t  term
LK
'last fit' 'age'
Ma Lx
1 0
0 1
Fr Ga(1,1) ga(1,2) Ga(2,1) Ga(2,2)
Le
Int Sip
va 1 ly (1,1) 1y (2,1) ly(3,1)
va 0 1y (1,2)
va 1 1y (2,2)
va 2 1y (3,2)
fr te(1,1) te(2,2) te(3,3)
Path Diagram
Ou nd=3
Notes: In this model
1) Raw data are being used from an SPSS file imported into LISREL.
2) The SE command indicates which variables are to be used in the analysis
3) New matrices are used -  the AL matrix which is used for the intercept
4) There are two aspects of the script used for the analysis
a. in the first part (the structural model) the Gamma matrix is used to test 
the effect of predictors on the latent variables for intercept and slope
b. in the second part the latent variables for intercept and slope are 
defined (by the measurements of depression at the three time points= 
equivalent to the measurement model).
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